Dynamics of bacterial biofilm predation by Vidakovic, Lucia & Drescher, Knut (Prof. Dr.)
Dynamics of Bacterial Biofilm
Predation
Dissertation
zur
Erlangung des Doktorgrades der
Naturwissenschaften
(Dr. rer. nat.)
dem Fachbereich Biologie
der Philipps-Universität Marburg
vorgelegt von
Lucia Vidakovic
aus Groß-Gerau
Marburg, März 2019
Erstgutachter: Prof. Dr. Knut Drescher
Zweitgutachter: Prof. Dr. Victor Sourjik
iii
Ehrenwörtliche Erklärung
Hiermit versichere ich, Lucia Vidakovic, die vorliegende Dissertation mit dem Titel:
Dynamics of Bacterial Biofilm Predation
ohne Hilfe Dritter und nur mit den angegebenen Quellen und Hilfsmitteln ange-
fertigt zu haben. Alle Stellen, die Quellen entnommen wurden, sind als solche
kenntlich gemacht worden. Diese Arbeit hat in gleicher oder ähnlicher Form noch
keiner Prüfungsbehörde vorgelegen.
Datum: Unterschrift:
iv
Summary
This thesis focused on two bacterial interactions with naturally-occurring preda-
tors.
The first project examined viral infection dynamics of Escherichia coli biofilms
with the lytic bacteriophage T7. By combining fluorescence confocal microscopy,
automated image analysis and molecular biology, this investigation provided new
mechanistic insights into biofilm matrix-mediated bacteriophage protection of en-
tire bacterial communities. Bacteria infected by bactriophages were reliably de-
tected with the use of genetically modified T7 bacteriophages, which resulted in the
production of a fluorescent protein by bacteriophage-infected bacteria. Exposure
of biofilms of varying ages to T7 bacteriophages revealed a biofilm development-
specific bacteriophage protection: Biofilms grown for up to 48 h in microfluidic
channels were susceptible to phage-mediated killing, but in contrast, biofilms that
were more than 60 h old survived during the constant influx of bacteriophages.
Bacteriophage protection of E. coli biofilms solely depends on the presence of one
component in the biofilm matrix, i.e., amyloid curli fibers. Moreover, the develop-
ment of protection temporally coincides with the production of curli fibers during
late stages of biofilm formation. To uncover this curli fiber-mediated protection
mechanism, the biofilm architecture was analyzed and bacteriophage virions were
visualized spatiotemporally in living bacterial and in vitro constructed artificial
biofilms. Together, the results demonstrate that curli fibers provide a close cell-
cell arrangement, filling space between the cells, so that bacteriophages cannot
invade the bacterial community. In addition, curli fibers are necessary and suf-
ficient to protect single cells from bacteriophage-mediated killing if bacteria are
completely encapsulated by matrix. In conclusion, community and single-cell stud-
ies comprehensively showed how amyloid curli fibers confer collective, as well as,
individual protection to biofilm-dwelling cells against bacteriophage infection.
The second part of the thesis investigated the interaction of Vibrio cholerae with
human macrophages (cells of the innate immune system responsible for clearance
of bacteria during invasion of human tissues). V. cholerae, traditionally known to
colonize the small intestine and cause the diarrheal cholera disease, was able to
attach to the surface of macrophages in vitro. Once attached, bacterial biofilms
were formed on the macrophage, followed by biofilm dispersal. Comprehensive
examination of the interaction dynamics showed that colonization is a flagella and
vtype IV pili-driven process. The polar flagellum, together with mannose-sensitive
hemagglutinin type IV pili, facilitates bacterial attachment to the macrophage
surface. During biofilm growth, V. cholerae initiates the production of toxin-
coregulated type IV pili, which enhances cohesion between biofilm-dwelling bac-
teria and prevents complete dispersal of biofilms. Co-incubation studies revealed
that production of one type of pili, mannose-sensitive hemagglutinin pili or toxin-
coregulated pili, by motile V. cholerae cells is necessary and sufficient for attach-
ment and biofilm formation. Major biofilm matrix components described for V.
cholerae biofilms (RbmA, RbmC, Bap1, and VPS) are dispensable for colonization
of human macrophages in vitro. These observations demonstrate an inversion of
the classical predator-prey concept, by which bacteria act collectively via biofilm
formation to evade phagocytosis.
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Zusammenfassung
Die vorliegende Arbeit befasste sich mit der Interaktion zwischen Bakterien und
zwei, natüurlich in der Umwelt, vorkommenden Präadatoren.
Das erste Projekt befasste sich mit den Dynamiken der Infektion von Escherichia
coli AR3110 Biofilmen mit T7 Bakteriophagen (vereinfacht: Phagen). Konfokale
Fluoreszenzmikroskopie mit anschließender Bildanalyse ermöglichte eine genaue
Aufklärung, wie bakterielle Gemeinschaften durch die Produktion von Biofilm-
Matrix vor einer Infektion durch Bakteriophagen geschützt werden. Der Einsatz
von genetisch modifizierten T7 Phagen und die darin resultierende Produktion
von sfGFP durch infizierte Bakterien ermöglichte eine präzise Detektion von in-
fizierten Wirtszellen. Als Biofilme verschiedenen Alters T7 Phagen ausgesetzt wur-
den, konnte in Abhängigkeit des Entwicklungsstadiums der Biofilme ein Schutz
vor einer Phageninfektion beobachtet werden. Bakterien innerhalb von Biofil-
men bis zu einem Alter von 48 h konnten erfolgreich von T7 Phagen infiziert
werden. Demgegenüber konnten Biofilme ab einem Alter von 60 h nicht von
T7 Phagen infiziert werden. Der Schutz von E.coli Biofilmen vor einer Pha-
geninfekton hängt einzig und allein mit der Anwesenheit von sogenannten amy-
loiden Curli Fibern innerhalb der Biofilm-Matrix zusammen. Das Ausbleiben
der Phageninfektion ist zudem zeitlich geknüupft mit der Produktion von Curli
Fibern. Der Mechanismus, wie Curli Fibers die Phageninfektion verhindern, kon-
nte anhand der Analyse der Biofilm-Architektur sowie der raumzeitlichen Visual-
isierung von Phagen-Partikeln während der Co-Inkubation mit bakteriellen Biofil-
men oder in vitro hergestellten künstlichen Biofilmen aufgeschlüsselt werden. Curli
Fibers sorgen für einen engen Zusammenhalt der Bakterien untereinander und
füllen den Freiraum zwischen benachbarten Zellen, sodass die Invasion der bak-
teriellen Gemeinschaft durch Phagen blockiert wird. Zudem ist die Produktion
von Curli Fibers notwendig als auch ausreichend, um einzelnen Zellen Schutz vor
Phageninfektion zu gewähren. Zusammenfassend konnte in Untersuchungen auf
Populations- sowie Einzelzellebene gezeigt werden, dass Curli Fibers Biofilme im
kollektiv, aber auch individuelle Curli Fibers produzierende Zellen vor einer Infek-
tion durch Phagen schützen.
Im zweiten Projekt wurde die Interaktion zwischen Vibrio cholerae und humanen
Makrophagen untersucht. V. cholerae besiedelt üblicherweise den Dünndarm und
löst die Durchfallerkrankung Cholera aus. Makrophagen sind Teil des angeborenen
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Immunsystems und verantwortlich für die Beseitigung von eingedrungenen Bakte-
rien in Geweben. Untersuchungen konnten zeigen, dass V. cholerae in der Lage
ist, sich in vitro an Makrophagen anzuheften. Im Anschluss folgte die Biofilm-
bildung auf der Oberfläche der Makrophagen, sowie darauffolgend das Auflösen
der bakteriellen Gemeinschaft. Unteruchungen zur Interaktionsdynamik konnten
zeigen, dass die Besiedlung der Makrophagenoberfläche von Flagellen sowie Pili
abhängig ist. Das polare Flagellum zusammen mit MSHA Pili ermöglicht die Ad-
häsion der Bakterien an die Oberfläche der Makrophagen. Während der Biofilm-
bildung produziert V. cholerae toxin-coregulierte Pili (TCP), welche für einen fes-
ten Zusammenhalt zwischen Zellen sorgen und zur unvollständigen Auflösung des
Biofilms beitragen. Weitere Interaktionsstudien haben gezeigt, dass V. cholerae
im Besitz eines polaren Flagellums auf die Produktion von nur einer Sorte von
Pili, MSHA Pili oder TCP, angewiesen ist, um Biofilme auf der Oberfläche von
Makrophagen auszubilden. Hauptkomponenten der Matrix beschrieben für V.
cholerae Biofilme (RbmA, RbmC, Bap1 und VPS) sind nicht essentiell für die
Besiedlung von Makrophagen in vitro. Zusammenfassend zeigen diese Beobach-
tungen diese Beobachtungen eine neue Art von Zell-Zell-Interaktion, welche bisher
noch nicht für V. cholerae beschrieben wurde.
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1 Introduction
Bacteria are the most abundant organisms on earth. Despite their size of a few
micrometers, their existence is crucial for life on our planet. Bacteria are involved
in various biogeochemical cycles and colonization of higher organisms by bacteria
is indispensable [16].
1.1 Bacterial Biofilms in the Environment
In nature, bacteria exist in two distinct modes of life: planktonic cells and biofilms.
Biofilms, defined as mirobial communities attached to a surface, constitute the pre-
dominant bacterial lifestyle [7]. In these cellular consortia, bacteria are embedded
in a self-produced matrix of extracellular polymeric substances (EPS) [8].
Among bacteria, biofilm formation follows a regulated developmental process [9].
First, planktonic cells attach irreversibly to a surface, which is facilitated by pro-
teins or structures present on the bacterial cell surface (e.g. pili, flagella). Once
bacteria adhered, microcolony formation as well as biofilm maturation follows, dur-
ing which, growing cells surround themselves with matrix. Production of biofilm
matrix proceeds in a controlled manner, takes place in discrete regions inside the
community and is responsible for shaping the biofilm architecture. The establish-
ment of multicellular bacterial assemblies can be severely impaired by attenuation
in surface attachment or deficiency in biofilm matrix production. Biofilm dispersal
comprises the final stage in the developmental program, which is either an active
or passive process. Various environmental as well as bacterial-associated signals
are known to trigger release of cells from biofilms. Bacteria are then capable to
colonise new habitats and another cycle of biofilm formation can be initiated [10
15].
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Biofilm-dwelling bacteria are characterized by differential gene expression patterns.
These can arise from chemical concentration gradients (e.g nutrients, oxygen) that
prevail inside the three-dimensional structure, but also from stochastic gene ex-
pression [16]. As a result, subpopulations emerge in respect to biofilm matrix
production, antibiotic tolerance and also metabolic activity [1618] . Heterogene-
ity leads to cooperative as well as competitive interactions between bacteria and
these shape the behaviour of biofilms as a whole [19, 20].
Compared to the existence as an individual cell, being part of multicellular commu-
nities provides various benefits for bacteria, making biofilms a fundamental mode of
bacterial life. Biofilm growth promotes the acquisition of genetic material by hor-
izontal gene transfer, thereby contributing to the bacterial diversity [21]. Another
important feature related to biofilms is the protection of matrix-embedded bacte-
ria against environmental changes. Compared to single bacteria, biofim-dwelling
cells are capable to withstand environmental stress. The most common example
is the increased tolerance of biofilms towards antimicrobial agents making biofilms
a pervasive threat to human health. Bacterial survival can be attributed to the
failure of biocidal agents to penetrate the microbial community. In addition, de-
creasing metabolic activity of cells towards deeper regions of the community and
the existence of a transiently antibiotic-tolerant bacterial subpopulation, called
persister cells, contributes to insufficient eradication of biofilm-embedded bacte-
ria. Re-growth of surviving cells will then for example lead to chronic bacterial
infections in the human body [2225]. In addition to diminishing the antimicrobial
effect, biofilm formation greatly influences the outcome of predation by protozoans.
While planktonic cells are eliminated, matrix-embedded bacteria have been shown
to survive protozoan grazing [26, 27]. Other naturally occurring threats to bac-
terial life are bacteriophages as well as macrophages. Bacteriophages are viruses,
that use bacteria as their host for self-replication. Which strategies do bacteria
utilize to prevent infection by phages and whether biofilm formation is one of them,
is discussed in chapter 2. Macrophages are a type of immune cells, capable to carry
out elimination of bacterial cells by the uptake and ingestion of bacterial biomass.
Bacterial interactions with macrophages are discusses in detail in chapter 3.
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1.2 Aims of the Thesis
Life in communities, termed biofilms, has been recognized as a beneficial and suc-
cessful mode of life, as bacteria are more protected against environmental stress
compared to their individual counterparts [7]. How bacteria interact with natu-
rally occurring predators should be investigated with two examples. The aim was
to understand, how bacteria and their predators can co-exist in the environment.
Specifically, in the first project the interaction between E. coli biofilms and the
bacteriophage T7 was studied. Several questions were addressed in order to un-
derstand the mechanism of biofilm-bacteriophage (simply: phages) interactions:
1) Do biofilms intrinsically tolerate the presence of phages or does the survival
of bacterial communities depend on the developmental stage of the biofilm?
2) What is the mechanism of phage protection and is it associated to specific ma-
trix components?
The second part of the thesis involved studying the interaction between V. cholerae
and macrophages with respect to following questions:
1) Do macrophages phagocyte V. cholerae?
2) Can V. cholerae use the biotic surface of macrophages for biofilm formation?
3) What type of surface structures facilitate bacterial attachment to the surface
of macrophages?
4) How are bacteria held together in biofilms formed on the macrophage surface?
What are the components of the biofilm matrix?

2 Biofilm architecture confers
protection against viral infection
2.1 Introduction
2.1.1 Escherichia coli biofilms
Escherichia coli is a gram-negative bacterium belonging to the family of Enter-
obacteriaceae, present as a commensal in the human gut. However, pathogenic
strains of E. coli evolved, causing urinary tract infections or diarrhea [28, 29].
Surface colonization of E. coli is facilitated by proteins present on the bacterial
surface, e.g flagella or type I fimbriae [30, 31]. Once attached, bacteria are able to
form biofilms, where they encapsulate themselves in matrix. The composition of
the biofilm matrix is variable, depending on the bacterial strain and growth con-
dition. The polysaccharides cellulose, poly-N-1,6-acetylglucosamine and colanic
acids have been identified as matrix constituents. Proteinacious components can
involve Ag43, flagella and curli fibers [12].
Studies with E. coli W3110 and E. coli AR3110 macrocolonies grown on agar at
temperatures below 30 ◦C revealed a spatial distribution of individual components
of the biofilm matrix in the bacterial communities. Such an organization of the
biofilm matrix could be further observed for submerged biofilms grown on a glass
surface. In those bacterial communities, bacteria present near the surface surround
themselves with flagellar filaments. In contrast, cells located in the upper area are
encapsulated in a mesh made out of curli fibers, which represent the major protein
component of the E. coli biofilm matrix [12, 17, 32]. In E. coli AR3110 biofilms,
cellulose constitutes an additional component of the biofilm matrix, as cellulose
synthesis has been restored in E. coli AR3110. Since cellulose and curli fiber pro-
duction depends on the biofilm master regulator CsgD, both matrix components
share the same spatial distribution in E. coli AR3110 biofilms [33]. Flagella, cellu-
lose and curli fibers together are equally important for the architecture of biofilms.
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Loss of one matrix constituent is sufficient to induce architectural differences to
the biofilms [32, 33]. Production of flagella, curli fibers and cellulose in discrete
areas of the bacterial community arise from diversification in gene expression and
the inverse regulation of flagella and curli fibers in E. coli [17, 34, 35].
2.1.2 Inverse regulation of flagella and curli fibers in E. coli
In E. coli, production of curli and flagella is facilitated by two regulatory cascades.
They are inversely regulated, with one master regulator present on top of each
cascade [32, 35].
Genes involved in flagella assembly are organized in several operons. Tempo-
ral expression of these operons follows a highly regulated process, which ensures
timed production of proteins required during the steps of flagella assembly. Flag-
ellar promoters are divided into three classes: class I, II and III [3638]. The class
I promoter corresponds to a single operon flhDC, encoding the flagella master reg-
ulator. The proteins FlhD and FlhC form a complex, which is a transcriptional
activator needed together with σ70 for the transcription from class II promot-
ers [39]. Class II promoters belong to operons that encode proteins involved in
assembly of the basal body and the hook of the flagellum. Furthermore, FlhDC-
dependent transcription leads to the production of the σ-factor FliA (σ28) and
its anti-σ-factor FlgM [36]. The interplay between FliA and FlgM ensures tran-
scription from class III, once the basal body and the hook have been assembled
[4042]. Class III promoters initiate for example transcription of genes encoding
the flagella subunit or chemotaxis proteins [36].
Curli fiber biogenesis requires the master biofilm regulator CsgD , whose expres-
sion depends on several proteins, including the sigma factor RpoS [4345]. CsgD
in turn activates transcription of the csgBAC operon and yaiC, involved in curli
fiber and cellulose production, respectively [46, 47].
Both regulatory cascades consist of proteins that modulate each others expression.
CsgD, for example, has been shown to inhibit transcription of fliA and flgM [48].
Moreover, modulating the intracellular ci-di-GMP concentration by the action of
phosphodiesterases and diguanlyate cyclases further favors one cascade over the
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other. In addition, the flagella regulatory network encodes the FliA-dependent
DNA binding protein FliZ. Binding of FliZ to RpoS-dependent promoters thus
interferes with RpoS-dependent gene expression, thereby inhibiting curli fiber pro-
duction [35, 49, 50].
2.1.3 Amyloid curli fibers
Curli fibers are amyloid proteinacious filaments produced by enteric bacteria, such
as Escherichia coli or Salmonella spp. [51]. Amyloids are characterized as ß-sheet
rich proteins, where the ß-sheets are aligned parallel and each ß-strand perpendic-
ular to the fiber axis [52, 53]. In contrast to amyloid formation by eukaryotic cells,
which results from protein misfolding and is associated with several human dis-
eases, production of amyloids by bacteria is a highly regulated process, important
for bacterial colonization of biotic and abiotic surfaces [54]. Curli fibers, desig-
nated as functional amyloids, are highly stable and their function in providing a
structural scaffold to bacterial communities underlines their crucial role in biofilm
development [33, 55]. Proteins required for curli fiber biogenesis in E. coli are en-
coded by two divergently transcribed operons: csgBAC and csgDEFG [43]. The
csgBAC operon encodes the major (CsgA) and the minor (CsgB) structural sub-
unit of the curli fiber. Transcription of the csgBAC operon is positively regulated
by the transcriptinal regulator CsgD [43, 46]. CsgB is the nucleator for CsgA and
crucial for fiber assembly on the bacterial surface. CsgB localizes to the bacterial
surface, where it rapidly assembles into aggregates with ß-sheet structures, which
then alter aggregation of CsgA. After initiation, the growing fiber serves as the
template for polymerization of secreted CsgA [56, 57]. In the absence of CsgB,
secreted CsgA remains unpolymerized and diffuses away from the bacterial surface
[56]. However, in vitro, after prolonged incubation, CsgA alone is able to form curli
fibers, that are indistinguishable from the ones formed in vivo [51]. To prevent
premature amyloid protein formation inside bacterial cells, the periplasmic protein
CsgC is produced, that acts as an inhibitor of amyloid formation [58]. Secretion of
CsgA and CsgB through the outer membrane is facilitated by the secretion com-
plex made out of CsgG, CsgE and CsgF [59, 60]. The periplasmic protein CsgE is
responsible for substrate specificity of the oligomeric outermembrane CsgG pore
[61]. CsgF is a surface-exposed component of the secretion machinery, that in-
teracts with CsgB and ensures its localization to the bacterial surface, which is a
prerequisite for curli fiber assembly [62]. For E. coli K-12 strains, production of
curli fibers has been shown to be optimal at temperatures below 30 ◦C. However,
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due to mutations in the promoter region of csgD or when grown in biofilms, bac-
teria are able to form curli fibers at 37 ◦C as well [63, 64]. Furthermore, clinical
isolates have been shown to produce curli fibers at 37 ◦C [65, 66]. Adaptation
in curli fiber production demonstrates their importance in colonization of various
bacteria. Curli fibers are just one type; bacteria have evolved numerous functional
amyloids that participate in biofilm formation as well as persistence in the host
[6769].
2.1.4 Bacteriophages
Bacteriophages, or phages, are viruses, that use bacteria as their host for self-
replication. Phages are considered as the most abundant entities on Earth; in
natural environments they outnumber bacteria by a factor of ten [70, 71]. Phages
are either lytic or temperate. Infection by lytic phages is characterized by ad-
sorption of phage virions to the bacteria cell surface and injection of the phage
DNA into the bacteria cell. Once inside, the phage shuts down the production of
bacterial proteins in favour of the expression of phage-encoded proteins. Progeny
phages will be assembled intracellular and released in the environment after caus-
ing bacterial cell lysis. In contrast, temperate phages can either enter the lytic
life cycle or their DNA will be replicated along with bacterial DNA, without the
production of progeny phages [72, 73].
The lytic bacteriophage T7 belongs to the Podoviridae and their bacterial host
is E. coli. The icosahedral capsid (head) of T7 phages is approximately 60 nm in
diameter and made out of 415 copies of the protein Gp10. T7 phages are char-
acterized by a noncontractile tail [7476]. Upon binding of the phage tail fibers
to the bacterial LPS, the phage ejects its double-stranded DNA into the bacterial
cell [7779]. During one infection cylce, approximately 200 progeny phages are
released [78].
2.1.5 Bacterial anti-phage defense systems
Since bacteria and phages are able to co-exist, it is not surprising, that bacteria
have evolved numerous strategies to resist phage infection. Bacteria can mod-
ify or block phage receptors, so that phages can not bind and inject their DNA
into the bacterial cell. In case phage DNA entered the cell, it can be subjected
to degradation due to bacterial restriction-modification systems or the adaptive
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immunity system CRISPR-Cas. The infection process can also be interfered by
abortive infection, that is accompanied by bacterial cell death. Cell death of a
phage infected cell can prevent the spread of phages and ensure survival of the
bacterial population. Simultaneously to the development of bacterial anti-phage
defense systems, phages on the other hand evolved strategies to counteract bacte-
rial resistance mechanisms. There is a constant arms race between bacteria and
phages in order to ensure persistence in the environment [8086].
2.1.6 Interactions of phages with bacterial biofilms
Co-existance of bacteria and phages is not only associated with the continuous
adaptation of single bacteria and their corresponding viral parasites. Taking into
account that bacteria mostly exist in matrix-embedded communities, such biofilms
are likely to encounter phage attack. Thus, the biofilm mode of bacteria itself
might contribute to co-existance [8789]. Indeed, bacteria residing in biofilms
have a higher survival rate in the presence of phages compared to planktonic bac-
teria [90, 91]. Biofilms have been shown to act as a physical barrier, thereby
limiting the diffusion of phages into the bacterial community [9194]. The emer-
gence of phages with biofilm matrix degrading properties further suggests that the
production of biofilm matrix very likely impedes phage infection and contributes
to stable co-existance [9597]. Despite the numerous studies demonstrating that
biofilms represent a protective environment against phage-mediated killing, the
protection mechanisms achieved by biofilm-associated factors still remains elusive.
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2.2 Results
During their lifecycle, bacteria often reside in microbial communities, called biofilms,
in which the cells are encapsulated in a self-produced matrix [7, 8]. In the envi-
ronment, biofilm-resident bacteria encounter a number of stresses and predation
by phages is one common example [94, 98]. To understand how bacterial commu-
nities and phages are able to coexist, phage predation in biofilms was investigated
using the lytic phage T7 and the biofilm-forming bacterial strain Escherichia coli
AR3110 as a model system. Genetic engineering in combination with time-resolved
microscopy uncovered how a single component of the biofilm matrix - amyloid curli
fibers - protects E. coli biofilms collectively, as well as single cells individually, from
phage infection.
The results described in this chapter have been published in Nature Microbiol-
ogy in January 2018 (L. Vidakovic, P.K. Singh, R. Hartmann, C.D. Nadell, K.
Drescher). Bacterial strain construction, fluorescent labelling of T7 phages, isola-
tion of the curli monomer CsgA and all phage-interaction assays were carried out
by myself. P.K. Singh was involved in construction of the T7 phage harbouring the
fluorescent reporter system to visualize phage-infected bacteria. R. Hartmann cre-
ated custom scripts for image analysis in MATLAB. C.D Nadell and K. Drescher
initiated the project.
2.2.1 Construction of a reporter system to visualize
phage-infected bacteria
In order to study the interaction between biofilms and phages in real-time, a
reliable method was required to distinguish phage-infected from non-infected bac-
teria. Therefore, a fluorescent reporter system was developed which enabled the
spatiotemporal visualization of phage-infected cells within a bacterial population
at the single-cell level (Figure 2.1 b). To detect phage-infected bacteria, lytic T7
phages were genetically modified by using the T7 R⃝ 415-1 Cloning Kit (Merck).
Here, two codon-optimized sfgfp (encoding superfolder green fluorescent protein),
under the control of the native T7 phi10 promoter, were introduced downstream of
gp10 (encoding the capsid protein Gp10) in the genome of phage T7 (Figure 2.1 a).
Infection of bacteria by these engineered T7 phages would result in bacterial syn-
thesis of sfGFP during the process of phage replication. Thus, sfGFP produced
by phage-infected bacteria serves as a fluorescent reporter for T7 phage infection.
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Successful modification of wild-type (WT) T7 phages was verified by sequencing
and fluorescence microscopy. Introduction of engineered T7 phages in close vicin-
ity to E. coli, constitutively expressing mRuby2, resulted in bacterial expression
of sfGFP (Figure 2.1 b). After bacterial cell lysis occurred, the progeny phages
were able to propagate to other viable cells as surrounding bacteria subsequently
started to produce sfGFP and lysed afterwards (Figure 2.1 c). In addition to fluo-
rescence microscopy, phage infection and sfGFP synthesis was validated in liquid
culture using a plate reader. Exposing exponentially growing E. coli cells to ge-
netically modified T7 phages resulted in reduction in OD600 nm confirming lysis of
bacterial cells (Figure 2.1 d). Simultaneously, fluorescence intensity measurements
confirmed the production of sfGFP during the continuous infection by progeny
phages.
Together, the results indicate that the fluorescent reporter system can be applied
to detect and track phage propagation throughout a bacterial population. These
engineered T7 phages were used as the viral agent in the following interaction
studies with biofilms.
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Figure 2.1: Construction of a fluorescent reporter system to visualize T7 phage-
infected bacteria (a) A schematic view of the T7 phage genome showing the corre-
sponding gene number for selected genes. sfgfp fused to the T7 phi10 promoter was
inserted downstream of gp10 in the T7 phage genome. (b) Exposing E. coli cells (con-
stitutively expressing the fluorescent protein mRuby2, shown in red) to engineered T7
phages resulted in production of sfGFP (shown in white). (c) Propagating waves of
phage infection were observed in a dense bacterial population, spread on LB agar. Cells
expressing sfGFP are shown in blue. (d) Phage infection of exponentially growing cells at
37 ◦C in liquid culture was monitored by measuring the optical density (OD600 nm) and flu-
orescence intensity (for sfGFP production). Addition of engineered T7 phages to growing
bacteria is indicated by the arrow (n=4).
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Figure 2.2: Temporal dynamics of E. coli biofilms exposed to T7 phages. Biofilms
of varying ages were exposed to engineered T7 phages for 12 h under constant flow.
Arrows indicate the time point when phages were added to the growing biofilms. For
bacterial communities up to an age of 48 h, bacteria were susceptible to T7 phage in-
fection. During co-incubation with phages, bacteria (in red) produced the fluorescent
infection reporter protein sfGFP (in cyan) until cell lysis (bottom left panel). In contrast,
biofilms grown for 60 h or more continued to grow in the presence of T7 phages (bottom
right panel). Plotted lines represent the mean bacterial biomass normalized to the initial
biomass at the beginning of phage exposure. Shaded areas represent the standard error
of the mean (nt=12=8, nt=24=10, nt=36=3, nt=48=4, nt=60=4, nt=72=7).
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Confocal fluorescence microscopy and subsequent image analysis revealed that
biofilms grown for up to 48 h experienced a decrease in biomass upon the intro-
duction of T7 phages into the mircrofluidic channels. During the continuous influx
of phages for 12 h, bacteria constitutively expressing mRuby2 (shown in red) pro-
duced sfGFP (shown in cyan) until cell lysis (Figure 2.2). However, biofilms older
than 60 h showed only a few phage-infected cells and continued to grow in the
presence of T7 phages (Figure 2.2). Thus, susceptibility to phage infection is in-
versely dependent on biofilm age.
Next, it was tested if the emergence of genetic resistance was the cause for sur-
vival of E. coli biofilms during phage exposure. For this, 72 h old biofilms were
disrupted, bacteria re-grown and exposed to engineered T7 phages in liquid cul-
ture. The addition of phages to exponentially growing cells resulted in a decrease
in OD600 nm and a simultaneous increase in fluorescence intensity, indicating suc-
cessful phage infection (Figure 2.3 a). As the progeny bacteria were not resistant,
the development of phage protection is not due to bacterial resistance.
Phage susceptibility of slow-growing cells was also investigated, as conditions
within bacterial sessile communities have been found to result in a decreased
growth rate [99, 100]. T7 phages were added at two time points during stationary
phase of bacteria growing in liquid culture, which led to a decrease in OD600 nm.
This demonstrates that a decrease in growth rate does not negatively affect the
process of T7 phage replication in E. coli (Figure 2.3 b).
To determine if the development of phage protection is solely dependent on the
phage species, T5 phages, which belong to a different family [101], were used
in the phage-biofilm interaction assay. During co-incubation, 48 h old biofilms
experienced a decrease in biomass, whereas 72 h old biofilms were able to survive
and continued to grow (Figure 2.4).
These observations indicate that E. coli gains a biofilm-associated protection
against both T7 and T5 phages. Furthermore, biofilms transition from suscep-
tible to protected at the same biofilm age, suggesting a common mechanism of
protection against phage infection (Figure 2.2, Figure 2.4).
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Figure 2.3: Cells from 72 h old biofilms and slow growing bacteria are susceptible
to phage infection. (a) Bacteria from 72 h grown E. coli AR3110 biofilms were suscep-
tible to T7 phage infection in liquid culture (incubated at 37 ◦C). The arrow indicates the
time point of phage addition. Production of sfGFP and bacterial cell lysis as part of the
phage infection process were monitored by measuring fluorescence intensity and optical
density (OD600 nm) respectively. Plotted lines represent the mean and shaded areas the
standard deviation (n=4). (b) Addition of T7 phages (indicated by arrows) at two time
points during stationary growth at 37 ◦C revealed that slow growing bacteria were readily
lysed by T7 phages. Bacterial growth was monitored by optical density (OD600 nm) mea-
surements. Plotted lines represent the mean and shaded areas the standard deviation
(n=8).
Figure 2.4: Exposure of E. coli AR3110 biofilms to T5 phages. Continuous influx of
T5 phages (addition of phages indicated by the arrow) into microfluidic channels for 12 h
resulted in phage-mediated cell lysis of 48 h old wild-type biofilms. In contrast, 72 h old
biofilms continued to grow in the presence of phages. Plotted lines represent the mean
bacterial biomass normalized by the initial biomass at the beginning of phage exposure.
Shaded areas represent the standard error of the mean (nt=48=12, nt=72=9).
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2.2.3 Amyloid curli fibers confer protection against phage
infection
In biofilms, bacteria embed themselves in a self-produced matrix that protects bac-
terial communities from various exogenous stressors, including phages [90]. Hence,
the biofilm matrix constituents of E. coli were investigated to determine the mech-
anism of how biofilms gain protection against phages. For this, mutants lacking
different matrix components were constructed: flagella (∆fliC ,∆flhDC ), cellulose
(∆bcsA), poly-N-acetylglucosamine (∆pgaC ), colanic acid (∆wcaE ), type I fim-
briae (∆fimA) or amyloid curli fibers (∆csgB). To identify the components of the
biofilm matrix that contribute to phage protection, 72 h old biofilms formed by
these matrix mutants were exposed to engineered T7 phages for 12 h under con-
stant flow. Biofilms formed by bacteria deficient in amyloid curli fiber biogenesis
(∆csgB) were susceptible to phage infection, as the bacterial biomass decreased
during co-incubation with phages (Figure 2.5 a). Ectopic expression of csgB in the
∆csgB background (∆csgB , PcsgB -csgB) successfully restored the survival phe-
notype. For biofilms lacking any of the other matrix components, reduction in
biomass could not be observed (Figure 2.5 a). Thus, the presence of curli fibers
is essential for phage protection and enables biofilm survival in the presence of T7
phages.
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Figure 2.5: Amyloid curli fibers as part of the matrix protect E. coli AR3110 bioflms
from phage infection. (a) Biofilms formed by matrix mutants were grown for 72 h in mi-
crofluidic channels and exposed to engineered T7 phages for 12 h under constant flow.
Bacteria deficient in curli fiber assembly (∆csgB) were susceptible to phage infection.
Ectopic expression of csgB under control of the native promoter successfully restored
the protection phenotype. Mutants lacking any other matrix component (flagella: ∆fliC,
∆flhDC; cellulose: ∆bcsA; poly-N-acetylglucosamine: ∆pgaC; colanic acid: ∆wcaE ;
type I fimbriae: ∆fimA) were protected from phage infection. Plotted lines represent
the mean biomass normalized to the initial biomass and shaded areas represent the
standard error of the mean (n∆fliC=3, n∆flhDC=5, n∆bcsA=4, n∆pgaC=5, n∆wcaE=5, n∆csgB=3,
n∆csgB, PcsgBAC-csgBAC=3). (b) Monitoring transcription of the curli operon csgBAC with the
fluorescent reporter protein mKate2 and (c) visualization of curli fibers by immunoflu-
orescence staining during biofilm growth revealed curli production during late stages of
biofilm formation. Confocal fluorescence images were taken every three hours. For every
imaging event the heatmap displays the fluorescence intensity values along the vertical
axis.
To understand the curli-mediated protection mechanism found in older biofilms,
the transition from being susceptible to protected was examined. Phage protection
is facilitated by curli fibers as their absence in 72 h grown biofilms results in phage
predation (Figure 2.5 a). Thus, susceptibility to phage infection in early stages
of biofilm growth could correspond to the absence of curli fibers in the biofilm
matrix. A reporter strain, with the fluorescent protein mKate2, was constructed
to monitor transcriptional activity of the csgBAC operon every 3 h throughout
biofilm growth for 72 h (Figure 2.5 b). Additionally, amyloid curli fibers were
visualized by immunofluorescence staining of biofilms formed by E. coli expressing
CsgA with a C-terminal 6x His-Tag (Figure 2.5 c). During the initial 40 h of
biofilm growth, expression of the fluorescent transcriptional reporter mKate2 could
not be observed (Figure 2.5 b). Consistently, fluorescent anti-6x-His antibodies
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were not visualized as well (Figure 2.5 c). Hence, the csgBAC operon was not
transcribed and curli fibers were not produced. However, between 40 h and 50 h of
growth, individual cells within the continuous bacterial flat layer started to produce
mKate2 and anti-6x-His antibodies were detected around them. Afterwards, as
the biofilm grew in height and developed a tower-like three-dimensional structure,
the amount of mKate2-producing cells increased continually. At the same time,
fluorescent antibodies were detected around these cells transcribing the csgBAC
operon. When E. coli biofilms grew in height, curli-producing cells predominantly
localized in the upper region of the biofilms (Figure 2.6 a-e). Here, nearly all
cells produced curli fibers, thereby creating a continuous mesh spanning the upper
part of E. coli biofilms as visualized by immunofluorescence staining (Figure 2.6 d).
Towards the bottom layer of the biofilm, fewer cells were surrounded by curli fibers.
Monitoring curli transcription and production spatiotemporally throughout biofilm
growth revealed a dynamic change in biofilm matrix composition with curli fibers
being produced during late stages of biofilm formation.
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Figure 2.6: Heterogeneous transcription and production of curli fibers in wild-type
E. coli biofilms. (a)-(e) In 72 h grown biofilms bacteria located in the upper part of the
biofilm predominantly produced the curli transcriptional reporter mKate2 (blue). (b)-(e)
Detailed view of one selected layer in the upper region (indicated by the dashed line and
arrow in cyan) shows that mKate2-producing cells were surrounded by curli fibers, as
visualized by immunofluorescence staining (red). Bacteria constitutively expressed the
fluorescent protein mKOkappa (yellow) (n=3).
Curli fiber production temporally coincided with the development of phage pro-
tection. Therefor, it was tested if biofilms formed by E. coli overexpressing curli
fibers can survive phage attack at an earlier biofilm age as compared to the wild
type. By the insertion of a point mutation in the promoter of the biofilm master
regulator CsgD, a constitutive expression of curli fibers was achieved [102]. These
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cells showed overall faster biofilm formation. When exposed to engineered T7
phages, biofilms grown for 24 h or more were able to survive (Figure 2.7). As ac-
celerated curli production resulted in advanced phage protection, it demonstrated
that the development of phage protection is directly dependent on the presence of
curli fibers in biofilms.
Figure 2.7: Overexpression of biofilm matrix results in phage protection at a
younger biofilm age. Biofilms formed by cells overexpressing curli fibers were exposed
to engineered T7 phages for 12 h and changes in bacterial biomass were monitored
by fluorescence confocal microscopy. The time point of phage addition to the growing
biofilms is indicated by the arrows. Biofilms up to an age of 12 h were susceptible to
phage-mediated killing. However, survival could be observed at an early biofilm age of
24 h. Plotted lines represent the mean bacterial biomass normalizd to the initial biomass
and shaded areas the standard error of the mean (nt=6=4, nt=12=8, nt=24=8, nt=48=6).
Together, these results reveal the crucial role of amyloid curli fiber production in
the protection against infection by phages. Although the production of curli fibers
is heterogeneously distributed across E. coli biofilms, assembly of the curli fiber
mesh in the upper region of the biofilm is sufficient to confer collective protection
against phage infection.
2.2.4 Monitoring the transcription of genes involved the
production of biofilm matrix
Curli fiber production is temporally associated with the development of phage pro-
tection, making curli an indispensable constituent of the biofilm matrix. Other ma-
trix components such as flagella, cellulose, colanic acid, poly-N-acetylglucosamine
and type I fimbriae contribute to biofilm formation in E. coli. Here, these ma-
trix components were investigated for their role in the spatiotemporal changes of
the biofilm architecture during curli-mediated phage protection. As previously
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described for curli fibers, the transcriptional activity of matrix-encoding genes
was monitored throughout biofilm growth using the fluorescent reporter protein
mKate2.
Flagella facilitate biofilm initiation as they promote surface attachment [30]. Fluo-
rescence confocal microscopy revealed that bacteria transcribe the flagella subunit
fliC (further referred as PfliC -ON) from the initiation of biofilm formation and
PfliC -ON cells were present throughout growth for 72 h (Figure 2.8 a). However,
the fraction of PfliC -ON cells changed during biofilm development. Before curli
fibers were produced, all cells transcribed fliC homogeneously. In contrast, when
biofilms were more than 40 h old and production of curli fibers occured, fliC was
primarily transcribed by cells located at the bottom of the biofilm (Figure 2.8 b-
d). In the upper region, only a few cells appeared to be in a PfliC -ON state
(Figure 2.8 e-f). Hence, during late stages of biofilm development, production of
the biofilm matrix components flagella and curli is limited to the cells of the lower
and upper layers of the biofilm, respectively.
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Figure 2.8: Transcription of fliC during growth of wild-type biofilms. (a) Monitor-
ing the production of the fluorescent protein mKate2 as a reporter for transcription of
fliC (encoding the flagella subunit). Fluorescence images were taken every three hours
throughout biofilm growth for 72 h. For every imaging event the heatmap displays the
mKate2 expression profile along the vertical axis of the biofilm. The colormap was ad-
justed to the minimum and maximum fluorescence intensity values of the curli transcrip-
tional reporter (Figure 2.5) (n=3). (b)-(f) Cells transcribing fliC (shown in green) were
heterogeneously distributed across different layers of 72 h old biofims. Bacteria were
constitutively expressing mKOkappa (shown in purple) (n=3).
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In E. coli AR3110, production of cellulose has been restored. Therefore, these bac-
teria are able to produce cellulose and use it as another constituent of the biofilm
matrix [33]. To investigate cellulose production, the transcription of dgcC, encod-
ing a diguanylate cyclase required for cellulose biosynthesis was monitored using
the fluorescent protein mKate2 (Figure 2.9 a). During biofilm growth for 72 h,
the mKate2 expression pattern was similar to that observed for the curli operon
csgBAC (Figure 2.5 b). Biofilm-resident cells producing mKate2 started to appear
approximately after 50 h of growth and localized in the upper region of the bacterial
community. Overall, compared to csgBAC, lower mKate2 fluorescence intensity
values were obtained in case of dgcC. For colanic acid (PwcaE -mKate2 ), poly-N-
acetylglucosamine (PpgaC -mKate2 ) and type I fimbriae (PfimA-mKate2 ), expression
of the fluorescent transcriptional reporter mKate2 could not be detected during
biofilm growth (Figure 2.9 b-d). Monitoring transcriptional promoter activity of
operons involved in matrix production suggests that, in addition to curli fibers,
bacteria only produce flagella and cellulose as part of their matrix.
Major changes in biofilm matrix composition involve spatiotemporal dynamics
in production of curli fibers, flagella and cellulose during biofilm growth. Tran-
scriptional activity of genes involved in colanic acid, poly-N-acetylglucosamine and
type I fimbriae production did not coincide temporally with the development of
phage protection.
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Figure 2.9: Transcription of genes involved in biofilm matrix production. Tran-
scriptional reporter fusions using the fluorescent protein mKate2 were constructed and
mKate2 expression was monitored every 3 h throughout biofilm growth for 72 h. The
mKate2 fluorescence values were adjusted to the minimum and maximum obtained for
the csgBAC operon transcriptional reporter (Figure 2.5) and displayed along the height
of the biofilm for each imaging time point. Transcription was monitored for (a) dgcC en-
coding a diguanylate cyclase required for cellulose biosynthesis (n=3), (b) wcaE involved
in colanic acid synthesis (n=3), (c) pgaC that codes for a poly-N-acetylglucosamine syn-
thase (n=4) as well as (d) fimA encoding the type I fimbriae major subunit (n=3).
2.2.5 Biofilm architecture impacts phage mobility in
biofilms
Alterations in matrix composition during the process of biofilm development con-
tribute to the re-organization of the biofilm architecture [103]. In E. coli, biofilm
growth is accompanied by changes in the matrix composition with increasing
biofilm age. This is seen by the initiation of curli fiber production during late stages
of biofilm development, which is essential for bacterial survival against phage at-
tack. Curli fibers have been shown to promote cell-to-cell interactions [104]. Taken
together, it led to the hypothesis that curli fibers induce architectural changes to
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the biofilms, which protect the cells from phage infection. To test this, the cell
density of 72 h grown biofilms formed by wild-type and ∆csgB cells was compared.
Analysis of the biofilm architecture revealed that the cells in ∆csgB biofilms are
less tightly packed compared to the wild type (Figure 2.10 a), suggesting that
a wider spatial separation of bacteria in the absence of curli fibers leaves bacte-
ria susceptible to phage attack. Further, it was hypothesized that the extent of
cell packing is directly linked to phage mobility into bacterial communities. The
ability of T7 phages to invade bacterial communities was investigated by using
fluorescently labelled wild-type T7 phages (Alexa Fluor 488). In the presence of
72 h old wild-type biofilms, fluorescently labelled phages were exclusively found in
the outer periphery of the bacterial community (Figure 2.10 b). Invasion was also
tested for biofilms lacking cellulose (∆bcsA) , poly-N-acetylglucosamine (∆pgaC )
and colanic acid (∆wcaE ). For these biofilms, identical results were obtained. In
contrast, biofilms lacking curli fibers (∆csgB) showed permissive phages invasion
(Figure 2.10 f). This indicates that curli fibers protect bacteria against infection
by T7 phages on the community level, by providing a close cell-to-cell arrangement
which prevents the diffusion of phages into the biofilm.
Figure 2.10: Biofilm architecture prevents invasion of biofilms by T7 phages in the
presence of curli fibers. (a) Imaging of bacterial communities at single-cell resolution
and biofilm reconstruction revealed a tighter cell packing in wild-type biofilms as com-
pared to biofilms formed by ΔcsgB. Plotted lines represent the mean and shaded areas
represent the standard error of the mean (nWT=9, nWT=9). (b)-(f) Localization of fluo-
rescently labelled T7 phages (cyan) after co-incubation with 72 h old biofilms (red) for
8 h displayed as maximum intensity z-projections. In case of (b) wild-type biofilms and
ones lacking (c) cellulose, (d) poly-N-acetylglucosamine or (e) colanic acid, fluorescently
labelled T7 phages accumulated in the outer periphery only. (f) In contrast, phages were
able to penetrate bacterial communities impaired in curli fiber production.
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mesh, fluorescently labelled phages could not invade artificial biofilms regardless
of the bead size (Figure 2.11 d). In vitro polymerized curli fibers permitted fluo-
rescently labelled T7 phages to diffuse into the three-dimensional mesh. However,
the branched curli fiber network prohibited T7 phages from passing through (Fig-
ure 2.11 b). Co-localization of T7 phages with curli fibers was further confirmed
by scanning electron microscopy (Figure 2.11 c). Taken together, the distribution
of curli fibers around and between cells/beads (Figure 2.11 e) was sufficient to
prevent invasion of biofilms by T7 phages.
Figure 2.11: Construction of biofilms in vitro confirms cell spacing as a determi-
nant for phage invasion of bacterial communities. (a) Scanning electron microscopy
confirmed the successful polymerization of the purified curli monomer CsgA into curli
fibers in vitro. (b) Fluorescently labelled phages (cyan) were able to penetrate the curli
fiber network (orange, immunofluorescence staining). (c) T7 phages were trapped in-
side the fiber network (indicated by the arrows). (d)+(e) Construction of biofilms in vitro
with curli fibers as the matrix component and fluorescent beads representing bacterial
cells. Fluorescently labelled phages (cyan) were able to penetrate clusters made out of
beads that are 1 μm in diameter, but not clusters made out of 0.5 μm sized beads. How-
ever, when beads were entangled in the curli fiber mesh, phages were not able to invade
artificial biofilms.
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Visualization of fluorescently labelled T7 phages during co-incubation with biofilms
formed by wild-type cells, ∆csgB and other matrix mutants established the re-
quirement of curli fiber production against phage invasion (Figure 2.10 b-f). How-
ever, for flagella mutant biofilms (∆flhDC, ∆fliC ) inconsistent results were ob-
tained regarding the spatial distribution of T7 phages. Biofilms lacking the flagella
master regulator FlhDC prevented T7 phages from penetrating into the bacterial
community (Figure 2.12 b). On the other hand, T7 phages were able to invade
∆fliC biofilms (Figure 2.12 c) and appeared in different layers of the bacterial
community (Figure 2.12 d). To investigate the mechanism of how different flagella
mutant biofilms either allow or prevent T7 phages from diffusing into the bacte-
rial community, the biofilm architecture was analysed with respect to cell density.
Single-cell analysis revealed that in 72 h old ∆flhDC and wild-type biofilms, the
bacterial cell density was similar, with a tendency towards a tighter cell packing
for ∆flhDC (Figure 2.12 a). In case of ∆fliC biofilms, local cell densities were
more uniformly distributed.
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Figure 2.12: Biofilm architecture and phage mobility varies between flagella mu-
tants (a) Single-cell analysis of the biofilm architecture revealed that cells in ∆fliC
biofilms are less densely packed as compared to wild-type or ∆flhDC biofilms. (b)+(c)
Spatial distribution of fluorescently labelled T7 phages varied after co-incubation with
72 h old ∆fliC or ∆flhDC biofilms for 8 h. (d) Fluorescently labelled phages were able
to penetrate into different layers and localized in cell-free regions of ∆fliC biofilms as
indicated by the yellow arrows (n=4).
Both mutants (∆fliC and ∆flhDC ) are deficient in flagella biogenesis, however
only the deletion of fliC introduced architectural changes to the biofilms. These
architectural differences were assumed to be associated with the inverse regulation
of flagella and curli which results in the exclusive production of either flagella or
curli by E. coli AR3110 [35]. Taking into account that FlhDC and FliC oper-
ate at different levels in the flagella regulatory network, it was hypothesized that
the fraction of curli-producing cells in the bacterial population differs in ∆flhDC
and ∆fliC biofilms. Specifically, loss of the flagella master regulator FlhDC was
believed to disrupt the flagella regulatory network and shift the bacterial popu-
lation towards curli production during biofilm development. To verify this, tran-
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scriptional activity of the curli operon csgBAC was monitored with a fluorescent
transcriptional reporter fusion (PcsgBAC -mKate2 ) and curli fibers were visualized
by immunofluorescence staining. Confocal microscopy of ∆flhDC biofilms grown
for 72 h confirmed that the bacterial community constituted curli-producing cells
(Figure 2.13 a). Because FliC operates downstream of FlhDC [105], the flag-
ella regulatory network was expected to be functional in ∆fliC cells, i.e., active
transcription from the fliC promoter would still take place. Therefore, it was hy-
pothesized that ∆fliC biofilms consist of a heterogeneous bacterial population (in
respect to curli fiber production), similar to the wild type. Fluorescent transcrip-
tional reporter fusions (PcsgBAC -mKate2, PfliC -sfgfp) confirmed that∆fliC biofilms
are built up of PfliC -ON as well as PcsgBAC -ON cells (Figure 2.13 b). However, due
to the deletion of fliC, PfliC -ON cells were deficient in flagella assembly. Curli pro-
duction was exclusively seen in PcsgBAC -ON cells (Figure 2.13 c). Consequently,
alterations in biofilm matrix composition allowed T7 phages to penetrate cell and
matrix-free regions of ∆fliC biofilms (Figure 2.14). However, the extent of curli
fiber production was sufficient to provide collective protection against phage in-
fection.
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Figure 2.13: Biofilms formed by two flagella mutants differ in curli production (a)
In 12 h old∆flhDC biofilms, almost all cells produced curli fibers (magenta, immnunoflu-
orescence staining), regardless of their spatial distribution within the community (n=3).
(b)+(c)∆fliC biofilms consisted of cells that were either transcribing flagella or curli. Bot-
tom layers of the biofilm consisted of cells transcribing flagella whereas cells in the upper
layers showed curli production (n=3).
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Figure 2.14: Visualization of curli fibers and fluorescently labelled T7 phages in
∆fliC biofilms. After co-incubation for 8 h, fluorescently labelled T7 phages (cyan) lo-
calized in close proximity to curli fibers (purple, immunofluorescence staining) in different
layers (I-IV) of 72 h old ∆fliC biofilms (n=5).
Figure 2.15: Curli fibers protect single cells from T7 phage infection. (a) Scanning
electron microscopy revealed that bacteria producing curli fibers can be completely em-
bedded in a mesh made out of curli fibers. (b)+(c) Bacteria (red) fully surrounded by curli
fibers (yellow) were able to grow in the presence of T7 phages. Cells not producing curli
fibers or ones that were partially covered were susceptible to phage-mediated killing.
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2.3 Conclusion and Discussion
Interactions between biofilms and phages are likely common in the environment,
since phages are the most abundant entities and biofilms constitute the predom-
inant mode of life of bacterial cells [70, 71, 106]. Despite the numerous studies
showing that biofilm formation and matrix production protect against phage in-
fection, there is a lack of information on how biofilms gain protection [87, 91, 93,
107] In this study, the infection dynamics of E. coli biofilms by lytic T7 phages
were investigated as one example, to understand the co-existence of phages and
biofilms as well as the mechanism of phage-biofilm interactions.
Real-time visualization of phage-infected cells in a bacterial population by the use
of genetically modified T7 phages together with fluorescence confocal microscopy
reliably revealed a biofilm development-specific mechanism of phage protection
(Figure 2.2). Survival of biofilms of a certain age coincides temporally with the
production of curli fibers. Curli fibers are solely responsible for conferring collec-
tive protection against phage infection by preventing phage diffusion into bacterial
communities formed by E. coli (Figure 2.5, Figure 2.10). In addition, production
of a curli fiber mesh is sufficient to protect bacteria on the single-cell level (Fig-
ure 2.15).
Complete investigation of the infection dynamics of E. coli biofilms was performed
in respect to T7 phages. However, biofilm age dependent phage protection could
be discovered for lytic T5 phages as well (Figure 2.4). For both types of phages,
the transition from being susceptible to protected occurred at the same biofilm
age. This suggests that the mechanism, discovered for T7 phages, confers protec-
tion against T5 phages as well. Therefore, bacterial survival in the presence of T5
phages is potentially also associated with the production of curli fibers. Collective
protection of E. coli biofilms emerges from the curli-mediated single cell protection
and dense cell packing. In contrast, the survival of bacteria at the biofilm bound-
ary depends on the protection of individual cells. There, bacteria are embedded
in a curli fiber mesh, that obscures the bacterial cell surface and prevents phages
from binding to their receptor located on the bacterial surface. At the same time,
curli fibers ensure a dense cell packing by filling the space between cells, which
limits phage diffusion. Due to the survival of the outer cell layer of the biofilm
and prevention of phage invasion, biofilms can collectively withstand phage attack.
Generation of a physical barrier and limiting the diffusivity of phages is indicated
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to be an important determinant on the outcome of phage predation [93]. It sug-
gests that curli fibers can protect E. coli biofilms from numerous phages; not only
T7 and T5 phages.
Production of curli fibers favors co-existance of phages and E. coli biofilms. How-
ever, curli fibers are not only made by E. coli. In biofilms formed by Salmonella,
curli fibers are part of the biofilm matrix as well [102]. Since both organisms exhibit
similarities in their biofilm matrix composition, the curli fiber-mediated protection
mechanism discovered for E. coli could potentially act in Salmonella biofilms and
affect their susceptibility to phage infection. Curli fibers are also found in other
members of the Enterbacteriacae [66]. In addition, bacteria from different phyla
encode proteins showing homology to the curli formation system in E. coli [108].
Thus, curli-mediated phage protection could be a conserved mechanism, like var-
iuos other anti-phage defense systems [85], present in different bacterial species.
Owing to their high stability and resistance towards proteolysis [109], curli fibers
are advantageous structures and can not be degraded by matrix-degrading en-
zymes. Thus, it is possible that phages can not overcome this protection mecha-
nism by producing depolymerases.
The spatial organization of bacteria inside E. coli biofilms implicates a require-
ment for a certain community composition and structure to confer phage protec-
tion. E. coli biofilms are built up by flagella- and curli-producing cells (Figure 2.5,
Figure 2.8). Limited phage diffusion and collective protection can only emerge
because curli-producing cells shape the upper region of the biofilm and generate
a curli fiber mesh. This mesh acts as a physical barrier in the upper region, that
experiences constant exposure to phages. Flagella-producing cells benefit from the
presence of a curli fiber mesh, spanning the outermost region of the biofilm, and
survive. Therefore, curli fibers can be recognized as a public good. Since curli pro-
duction by all bacteria is not a prerequisite for survival of a single species biofilm,
it suggests that even multispecies biofilms could benefit from curli-producing cells.
However, the amount of curli-producing cells and their spatial distribution could
be the determining factors for collective protection.
Survival of E. coli biofilms is dependent on a sufficient production of curli fibers,
which coincides with a certain biofilm age. Initially phages can propagate succes-
fully in bacterial communities, which leads to an unstable co-existence between
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phages and bacteria. However, curli-mediated phage protection turns the inter-
action into a stable co-existence. These dynamics suggest, that the process of
biofilm formation and biofilm matrix production can determine the outcome of
phage-biofilm interactions in natural environments. Immature biofilms could be
the targets for phage replication.
This study comprehensively shows how the biofilm matrix composition at a cer-
tain biofilm age influences phage-biofilm interactions. Therefore, investigating
such interactions with biofilms of one age only is not sufficient to make general
conclusions about phage susceptibility of a given bacterial community. In future
studies, the biofilm developmental stage and biofilm matrix composition should
not be neglected. Understanding phage-biofilm interactions and biofilm protec-
tion mechanisms is not only important from the ecological point of view. The
medical area requires new strategies to combat antibiotic-resistant bacteria and
phage therapy is considered as one alternative. However, before phages can be
applied to combat bacterial infections, the outcome of exposing biofilm to phages
needs to be fully elucidated.
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2.4 Materials and Methods
2.4.1 Microbiological Methods
2.4.1.1 Growth of E. coli
Bacteria were grown overnight in 5mL lysogeny broth (LB) medium at 28 ◦C or
37 ◦C under shaking conditions (250 rpm). Whenever required, the growth medium
was supplemented with antibiotics. Antibiotic concentrations were used according
to Table 2.1. Bacterial strains used in this study are listed in Table S1 and Table
S2.
Table 2.1: Antibiotic concentrations used for selection of E. coli
Antibiotic Final concentration [µgmL=1]
Ampicillin 100
Kanamycin 50
Chloramphenicol 10
2.4.1.2 Storage of E. coli cells
Bacterial cells grown overnight were mixed with glycerol (final concentration 20%)
and stored at =80 ◦C.
2.4.1.3 Monitoring bacterial growth and phage infection
Bacteria were grown in plastic 96-well plates and the growth was monitored using
an automated plate reader (TECAN Spark 10M). For this, bacterial cells were
grown overnight and back-diluted in LB medium to an OD600 nm of 0.02. Individ-
ual wells were inoculated with 200 µL of the diluted bacterial suspension and the
plate was placed in the plate reader. Optical density (OD600 nm) and fluorescence
intensity was measured every 5min for 5-12 h. Between measurements, the plate
was shaking continuously (810 rpm). The temperature inside the plate reader was
set to 37 ◦C. When bacteria reached exponential growth phase, T7 phages were
added to a final concentration of 106 PFUmL=1. For infection of slow-growing
cells, T7 phages were added either at the beginning or 4 h after bacteria entered
stationary phase.
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2.4.1.4 Bacteriophage amplification and purification
For amplification of T7 phages, E. coli AR3110 was grown in LB medium sup-
plemented with 5mM MgSO4 at 37
◦C and 250 rpm shaking until an OD600 nm of
0.5. Subsequently, 2mL of a high-titer T7 phage lysate (108 PFUmL=1) was added
and bacterial cells were cultivated further at 37 ◦C and 250 rpm until the bacterial
culture cleared as a result of phage propagation. The clear lysate was filtered-
sterilized using a 0.22 µm filter and stored at 4 ◦C.
In order to amplify T5 phages, E. coli AR3110 was grown in LB medium sup-
plemented with 0.1mM CaCl2 at 37
◦C and 250 rpm shaking until an OD600 nm of
0.5. T5 phages were added and incubation at 37 ◦C and 250 rpm followed. The
clear lysate was stored at 4 ◦C.
For fluorescent labelling of T7 phages, further purification steps using a modified
version of the protocol described by Boulanger [110] were applied. Briefly, 500mL
of a T7 phage lysate was treated with DNaseI (final concentration 1 µgmL=1) for
30min at 37 ◦C and 250 rpm. NaCl was added (final concentration 0.5 µgmL=1)
and the lysate was stored for one hour at 4 ◦C. After centrifugation for 10min
at 4 ◦C and 8000 rpm, the T7 phage-containing supernatant was filter-sterilized
(0.22 µm pore size). Subsequently, PEG6000 was added to a final concentration of
10% and dissolved by gentle stirring. The phage lysate was stored overnight at
4 ◦C. The next day, precipitated phages were collected by centrifugation for 15min
at 4 ◦C and 8000 rpm, resuspended in 5mL PBS and stored at 4 ◦C, until they were
further purified by CsCl density gradient centrifugation.
For CsCl density gradient centrifugation, a 62.5% CsCl solution was prepared
by dissolving 25 g CsCl in 15mL H2O. Afterwards, the 62.5% CsCl solution was
diluted in phosphate buffered saline (PBS) to generate CsCl solutions with lower
densities (41.67%, 31.25%, 20.83%). The CsCl density gradient was generated
by layering solutions of decreasing density (2mL of each). Finally, 2mL of the
T7 phage suspension was layered on top of the density gradient and ultracen-
trifugation (105 g, 20 h, 4 ◦C) followed. Phage particles were collected and CsCl
was removed by dialysis against PBS at 4 ◦C. Prior to dialysis, a membrane with
12000-14000 MWCO was equlilibrated in H2O and then PBS for 1 h each. Subse-
quently, the membrane was filled with 300µL of the phage suspension and placed
in 500mL PBS for 2 h. Next, the membrane was transferred into 2 L PBS and
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dialysis followed overnight. The next day, purified T7 phages were collected and
stored at 4 ◦C until further use.
2.4.1.5 Determination of the phage titer
Whenever new phage lysates were generated, phages were purified or fluorescently
labelled, phage titer measurements were carried out. Phages were serially diluted
(up to 10=9 ) in LB medium. Afterwards, 50µL of the diluted phage suspension
was mixed together with 200 µL of exponentially growing E. coli AR3110 cells and
added to 5mL 0.7% LB agar. The LB agar was supplemented with 5mM MgSO4
or 0.1mM CaCl2 in case of T7 phages or T5 phages, respectively. Subsequently,
the mixture was poured onto a 1.5% LB agar plate and incubation at 37 ◦C for 6 h
followed. Phage plaques were enumerated and the phage titer (PFUmL=1) was
calculated.
2.4.1.6 Labelling of bacteriophages with Alexa Fluor 488
Bacteriophages were labelled with Alexa Fluor 488 (Cat-No. A30005, Thermo
Fisher Scientific) according to the protocol provided by the manufacturer and by
Slootweg et al. [111]. Briefly, 100µL of purified phages (concentration: 1012 PFUmL=1)
were mixed with 10 µL sodium bicarbonate (concentration: 1M) before 0.1mg
Alexa Fluor 488 5-TFP (dissolved in 10 µL dimethylformamide) was added. After
incubation for one hour at room temperature under continuous stirring, labelled
phages were separated from unbound dye by dialysis against PBS at 4 ◦C. Prior
to dialysis, a membrane with 12000-14000 MWCO was equlilibrated in H2O and
then PBS for 1 h each. Afterwards the membrane was filled with the phage-dye
mixture and dialysis followed. First, the membrane was placed into 500mL PBS
for 3 h. Afterwards, the membrane was transferred into 2 L fresh PBS and dialysis
occurred overnight. The next day, a third dialysis step for 4 h using 1 liter PBS
took place before fluorescently labelled phages were collected and stored at 4 ◦C.
2.4.2 Molecular Cloning
2.4.2.1 Heat shock transformation of E. coli AR3110
For lambda red recombineering and removal of antibiotic resistance cassettes, plas-
mid pKD46 or pCP20 was brought into E. coli AR3110 via heat shock transfor-
mation. For this, bacterial cells grown overnight were back-diluted 1:25 in 25mL
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fresh LB medium supplemented with the appropriate antibiotic and re-grown at
37 ◦C and 250 rpm shaking. Once the bacterial culture reached an OD600 nm of
0.5, cells were cooled down on ice for 10min. After centrifugation for 3min at
4 ◦C and 6000 g, bacteria were resuspended in 10mL ice-cold 0.1M CaCl2 followed
by incubation for 10min on ice. Subsequently, cells were harvested for 3min at
4 ◦C and 6000 g and resuspended in 500 µL of ice-cold 0.1M CaCl2/15% glycerol.
Immediately, chemically competent cells were used for heat shock transformation.
Chemically competent cells (100 µL) were mixed with 100 ng plasmid DNA and
incubated for 30min on ice. Subsequently, heat shock was applied by transfer-
ring bacteria into a 42 ◦C waterbath for 45 s followed by incubation on ice for
2min. Pre-warmed LB medium (500µL) was added and cells were recovered for
one hour at 37 ◦C and 550 rpm shaking. Afterwards, cells were plated on LB agar
supplemented with ampicillin and grown overnight at 28 ◦C.
2.4.2.2 Lambda red recombineering in E. coli AR3110
Genetic modifications in E. coli AR3110 were carried out using two lambda red
recombineering methods [112, 113].
All bacterial strains constitutively expressed a fluorescent protein constitutively
under control of the tac promoter (Ptac) lacking the lac operator. Biofilm matrix
mutants and wild-type E. coli AR3110 constitutively expressed mRuby2. Two E.
coli codon-optimized mRuby2 (with ribosomal binding sites) fused the tac pro-
moter were introduced together with a kanamycin resistance cassette into the E.
coli AR3110 genome at the attB site. When transcription was monitored using
a fluorescent reporter protein or the cells produced CsgA with a C-terminal 6x
His-Tag for immunofluorescence staining, bacteria expressed mKOkappa constitu-
tively. For this, a single mKOkappa with a ribosomal binding site fused to the
tac promoter and a kanamycin resistance cassette were inserted into the E. coli
AR3110 genome at the attB site.
Lambda red recombineering for gene deletions
In case of gene deletions, the gene of interest was replaced either with a chlo-
ramphenicol or kanamycin resistance cassette, amplified from pKD3 or pKD4,
respectively. In order to achieve successful genomic integration, oligonucleotides
were designed so that the resulting PCR product harbours 45 bp long homology
regions on both ends. After PCR purification, the DNA fragment was transformed
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into E. coli AR3110 (expressing the phage λ Red recombinase) via electropora-
tion. In order to generate E. coli expressing phage λ Red recombinase, E. coli
transformed with plasmid pKD46 was grown overnight at 28 ◦C. The following
day, 1mL of overnight culture was back-diluted into 50mL of fresh medium and
re-grown at 28 ◦C. Once the bacterial culture reached an OD600 nm of 0.1, arabinose
was added (final concentration 0.4%) and the cells were grown further until an
OD600 nm of 0.5. Afterwards, cells were incubated on ice for 5min and then har-
vested by centrifugation for 5min at 4 ◦C and 6000 g. Cells were resuspended in
25mL of ice-cold H2O, followed by centrifugation for 5min at 4
◦C and 6000 g. This
step was repeated twice, and then the pellet was resuspended in a final volume of
500 µL H2O, followed immediately by electroporation. Here, 50µL of electrocom-
petent cells were mixed with 100 ng of purified PCR product and transferred into
ice-cold electroporation cuvettes. Electroporation was performed using a Biorad
MicropulserTM (program Ec1, 1.8 kV ). Immediately after electroporation, 500 µL
of pre-warmed LB medium was added and the cells were incubated at 37 ◦C and
550 rpm shaking. After one hour, cells were plated on LB agar supplemented with
the appropriate antibiotic. The next day, successful genetic modification was ver-
ified by colony PCR. The antibiotic resistance cassette was flipped out using FLP
recombinase. Gene deletion as well as the subsequent flip-out of the antibiotic
resistance cassette was confirmed by DNA sequencing.
Removal of antibiotic resistance cassettes by FLP recombinase
E. coli AR3110 containing either the kanamycin or chloramphenicol resistance
cassette flanked by FRT sites was transformed with the plasmid pCP20 and grown
at 28 ◦C. After growth in liquid culture at 28 ◦C in the presence of ampicillin
bacteria were back-diluted 1:50 in LB medium and re-grown at 43 ◦C under non-
selective conditions. Once the culture reached an OD600 nm of 0.5, cells were back-
diluted for a second time and re-grown until an OD600 nm of 0.5. Finally, bacteria
were diluted and plated on LB agar. Loss of the selectable marker was confirmed
by plating clones on LB as well as on LB supplemented with chloramphenicol or
kanamycin.
Scarless lambda red recombineering
Scarless lambda red recombineering was applied for gene insertions and gene re-
placements in E. coli AR3110. This method is based on two recombineering steps.
First, a gene coding for a selectable marker is inserted into the locus to be modified,
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which is then replaced with a DNA fragment containing the desired modification.
In the first step, a kanamycin resistance cassette together with ccdB fused to a
rhamnose-inducible promoter (amplified from pKD45) was inserted into the locus
that was to be subjected to genetic modification. During the PCR, 45 bp long
regions were added to both ends of the DNA fragment for genomic integration
by homologous recombination. After PCR purification, the DNA fragment was
transformed into E. coli AR3110 expressing the phage λ Red recombinase as de-
scribed previously. In the second step, the whole cassette was exchanged with a
DNA fragment containing the desired modification. Again, the DNA fragment
was brought into E. coli AR3110 cells expressing phage λ Red recombinase via
electroporation. Counter-selection was performed by plating the cells on M9 agar
containing 0.2% L-rhamnose and 0.1% casamino acids. After three days of in-
cubation at 37 ◦C, the exchange of DNA fragments was verified by colony PCR.
Additionally, chromosomal modifications were confirmed by sequencing.
This method was utilized to generate E. coli strains expressing CsgA-6x-His-Tag.
Here, the native csgA of E. coli was exchanged with csgA containing a C-terminal
6x-His-Tag. Similarly, a point mutation was introduced into the promoter of csgD
to generate a curli overexpression strain [64]. For transcriptional reporter fusions,
mKate2 , encoding the fluorescent protein mKate2, was inserted into the native
locus of the promoter of interest, thereby extending the native operon or creating
an artificial operon. Ectopic expression of CsgB was achieved by inserting csgB
fused to its native promoter into the attB site of ∆csgB E. coli AR3110.
2.4.2.3 Isolation of plasmid DNA
Plasmid DNA was isolated from an overnight grown bacterial culture using the
NucleoSpin Plasmid EasyPure Kit according to the protocol provided by the man-
ufacturer (Macherey-Nagel).
2.4.2.4 Isolation of genomic DNA
Genomic DNA was isolated from overnight grown bacterial cells in liquid culture
using the NucleoSpin Tissue Kit (from Macherey-Nagel). The manufacturer's pro-
tocol was followed during the isolation procedure.
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2.4.2.5 Polymerase chain reaction (PCR)
For lambda red recombineering, DNA fragments were amplified using Q5 DNA
polymerase (M0491L, New England BioLabs). The composition of the reaction
mixture and the PCR program are listed in Table 2.2 and Table 2.3.
Table 2.2: PCR reaction mixture using Q5 DNA polymerase
Reagent
Q5 Reaction Buffer 1x
Q5 High GC Enhancer 1x
Oligonucleotide 1 10µM
Oligonucleotide 2 10µM
dNTP 0.2mM
Q5 DNA polymerase 1U
DNA template 50 ng genomic or plasmid DNA
Total volume 50µL
Table 2.3: PCR program using Q5 DNA polymerase
Step Temperature (◦C) Time (min) Cycle
Initial Denaturation 98 5 1
Denaturation 98 0.5
30Annealing 57-60 0.5Elongation 72 0.5/kbp
Final Elongation 72 10 1
Overlap extension PCR was used to join individual DNA fragments for lambda red
recombineering. For this, DNA fragments were amplified from plasmid or genomic
DNA using the standard Q5 polymerase protocol (Table 2.2, Table 2.3). Oligonu-
cleotides were designed so that each DNA fragment consisted of a 5' overhang that
is complementary to the end of the other DNA fragment to be joined with. Com-
plementary regions were 20-30 bp long with a melting temperature between 57 ◦C
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and 60 ◦C. After PCR purification of the individual fragments to be joined, two
consecutive PCRs followed. In the first PCR, the purified DNA fragments were
joined together. In the second PCR, oligonucleotides were added, which facilitated
fragment amplification. The composition of the reaction mixture for the first and
second PCR are listed in Table 2.4. The PCR programs are listed in Table 2.5.
Table 2.4: Overlap extension PCR: PCR reaction mixture for the first and second PCR
Reagent first PCR second PCR
Q5 Reaction Buffer 1x 1x
Q5 High GC Enhancer 1x 1x
dNTP 0.16mM 0.2mM
Q5 DNA polymerase 1U 1U
DNA template 1 pmol/ DNA fragment
10 µL PCR product
(first PCR)
Oligonucleotide 1 10µM
Oligonucleotide 2 10µM
Total volume 50µL 50 µL
Table 2.5: Overlap extension PCR: PCR program for the first and second PCR
first PCR second PCR
Step
Temperature
(◦C)
Time
(min)
Cycle
Time
(min)
Cycle
Initial Denaturation 98 2 1 2 1
Denaturation 98 0.5
13
0.5
30Annealing 57-60 0.5 0.5Elongation 72 0.5/kbp 0.5/kbp
Final Elongation 72 5 1 5 1
Colony PCR was performed to verify genetic modifications after lambda red re-
combineering. Here, a fraction of a grown colony after transformation was used
as the source of DNA for PCR. DNA fragments were amplified from the E. coli
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AR3110 genome using DreamTaq DNA polymerase (Cat-No. EP0702, Thermo
Fisher Scientific). The composition of the reaction mixture as well as the PCR
program are shown in Table 2.6 and Table 2.7.
Table 2.6: PCR reaction mixture using DreamTaq DNA polymerase
Reagent
Reaction Buffer 1x
Oligonucleotide 1 10 µM
Oligonucleotide 2 10 µM
dNTP 0.2mM
DreamTaq DNA polymerase 0.5U
DNA template bacterial cells
Total volume 10 µL
Table 2.7: PCR program using Dreamtaq DNA polymerase
Step Temperature [◦C] Time [min] Cycle
Initial Denaturation 95 10 1
Denaturation 95 0.5
30Annealing 57-60 0.5Elongation 72 1/kbp
Final Elongation 72 5 1
2.4.2.6 Agarose gel electrophoresis
Amplification of DNA fragments was verified by agarose gel electrophoresis on a
1% agarose gel. For visualization of DNA, 5µL of the PCR product was mixed with
1µL of a fluorescent DNA binding dye (N313-Kit, VWR) prior to electrophoresis.
As the DNA ladder, Gene Ruler DNA Ladder Mix from Thermo Fisher Scientific
(Cat-No. SM0331) was used.
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2.4.2.7 Treatment of PCR products with the restriction endonuclease
DpnI
When plasmid DNA was used as the template in a PCR reaction, 20Units of the
restriction endonuclease DpnI (R0176L, New England Biolabs) were added to the
completed PCR reaction mixture. After incubation for one hour at 37 ◦C, PCR
products were purified.
2.4.2.8 Purification of DNA fragments
PCR products were purified using the NucleoSpin Gel and PCR Clean-up Kit
according to the protocol provided by the manufacturer (Macherey-Nagel).
2.4.2.9 DNA sequencing
DNA sequencing was performed by Eurofins Genomics. Samples containing puri-
fied PCR products or isolated plasmid DNA were prepared according to the manu-
facturer's protocol. Sequencing results were analysed using the software SnapGene
(GSL Biotech LLC, Chicago).
2.4.2.10 Construction of fluorescent reporter T7 phages
For construction of the fluorescent reporter T7 phage, the T7 R⃝ 415-1 Cloning Kit
from Merck was used. The native T7 phi10 promoter, together with the Shine-
Dalgarno (SD) sequence located downstream of the phi10 promoter and the T7
tag leader sequence from gp10 were amplified by PCR from the T7 phage genome.
A second DNA fragment was generated by PCR harbouring, two E. coli codon-
optimized sfgfp separated by an SD sequence. Both DNA fragments were joined by
overlap extension PCR and the resulting PCR product was purified. Afterwards,
the DNA fragment was treated with the restriction endonucleases HindIII and
EcoRI and purified again. Subsequently, ligation of the DNA fragment with the
T7 R⃝ vector arms took place using a molar ratio of 3:1 (insert:vector). For the
composition of the ligation mixture see the manufacturer's manual. After ligatin
for 5 h at 16 ◦C, in vitro packaging of the T7 phages took place (see manufacturer's
protocol). The packaging reaction mixture was added to 200µL of exponentially
growing E. coli AR3110 together with 5mL 0.7% LB agar (supplemented with
5mM MgSO4) and poured onto a 1.5% LB agar plate. Plates were incubated at
37 ◦C for plaque formation. T7 phages from individual plaques were collected and
resuspended in 50µL of LB medium. These T7 phages were then used for T7 phage
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amplification in liquid culture. Successful modification of wild-type T7 phages was
verified by PCR and DNA sequencing. For this, 10µL of the T7 phage lysate was
heated for 10min at 95 ◦C and 1 µL was then used as the template for the PCR. Q5
DNA polymerase was used for DNA amplification. Oligonucleotides were designed
to hybridize upstream and downstream of the DNA fragment inserted between
both T7 R⃝ vector arms. The design and construction of the fluorescent reporter
T7 phage was done by P.K. Singh.
2.4.3 Biofilm-Phage Interaction Assay
2.4.3.1 Generation of microfluidic flow chambers
Microfluidic flow chambers, made from polydimethylsiloxane (PDMS), were 500µm
wide, 100µm high and 7mm long. PDMS pieces with five independent microflu-
idic flow channels were bonded to glass coverslips (0.17mm thickness) using oxygen
plasma. Each microfluidic channel was connected with PTFE tubing to a syringe.
The syringes were placed on a syringe pump (pico Plus, Harvard Apparatus) which
maintained a constant flow rate throughout the duration of the experiments.
2.4.3.2 Biofilm growth in microfluidic chambers
Bacterial cells grown overnight were washed with 0.9% NaCl and diluted 1:80 in
0.9% NaCl. Subsequently, microfluidic channels were inoculated and bacterial cells
were incubated for one hour at room temperature to facilitate bacterial attachment
to the glass surface. Afterwards, syringes filled with tryptone broth (10 gL=1) were
connected with PTFE tubing to the inlets of the microfluidic channels. During
assembly, the flow rate was set to 5µLmin=1. Non-attached bacterial cells were
removed by flushing the microfluidic channel with tryptone broth using a flow rate
of 50µLmin=1 for 45 s. Biofilms were grown in the presence of tryptone broth
under constant flow of 0.1µLmin=1 for a defined time at room temperature.
2.4.3.3 Biofilm-phage interaction experiments using flow chambers
For biofilm-phage interaction studies, grown E. coli AR3110 biofilms were exposed
to phages and the interaction was monitored by fluorescence confocal microscopy.
After biofilm growth for a defined time, syringes filled with T7 phages diluted in
tryptone broth supplemented with 5mMMgSO4 (final concentration of 10
7 PFUmL=1)
were connected with PTFE tubing to microfluidic channels containing grown biofilms.
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During exchange of tubings, the flow rate was set to 1 µLmin=1. Immediately after-
wards, the flow rate was decreased to 0.1µLmin=1. Grown biofilms were exposed
to a constant flow of phages for 12 h at room temperature. During phage exposure,
fluorescence images were taken using a confocal microsocpe.
When T5 phages were used for biofilm interaction studies, syringes were filled
with T5 phages diluted in tryptone broth (supplemented with 0.1mM CaCl2) to
a final concentration of 109 PFUmL=1.
2.4.3.4 Visualization of curli fibers in biofilms
The presence of curli fibers in biofilms was visualized by immnofluorescence stain-
ing. Grown biofilms, formed by E. coli AR3110 cells expressing CsgA with a
C-terminal 6x-His-Tag, were incubated with anti-6x-His-Tag antibodies conju-
gated to Alexa Fluor for one hour prior, as well as during, confocal imaging.
For this, syringes filled with antibodies diluted in tryptone broth (final concentra-
tion 0.4 µgmL=1) were connected with PTFE tubing to the microfluidic channels
containing grown biofilms. During insertion of the tubing the flow rate was set to
1µLmin=1. Afterwards it was decreased to 0.1 µLmin=1.
2.4.3.5 Exposure of planktonic E. coli AR3110 cells to bacteriophages
E. coli AR3110 cells expressing CsgA-6x-His-Tag were grown in LB medium for 5 h
at 37 ◦C and 250 rpm. Bacterial cells were back-diluted (1:100) in tryptone broth
and re-grown overnight for curli fiber production at 28 ◦C and 250 rpm shaking.
The next day, 50 µL of the bacterial suspension was incubated with anti-6x-His-
Tag antibodies conjugated to Alexa Fluor (final concentration 0.8µgmL=1) for
1 h under constant shaking at room temperature. Afterwards, bacteria were in-
troduced into microfluidic channels and allowed to attach to the poly-L-lysine
coated glass surface for 30min. Syringes filled with T7 phages (final concentration
108 PFUmL=1) and 0.2 µgmL=1 anti-6x-His-Tag antibodies conjugated to Alexa
Fluor (both diluted in tryptone broth) were connected with PTFE tubing to the
mircrofluidic channels. The flow rate was set to 0.1 µLmin=1. Throughout the
exposure of single cells to phages at room temperature, fluorescence images were
taken using a confocal microscope.
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2.4.3.6 Expression and purification of the curli monomer CsgA
The curli monomer CsgA was purified by affinity chromatography from an E. coli
Rosetta DE3 lysate. For this, a plasmid was constructed based on the expression
vector pET-24d (Novagen). The plasmid was designed such that csgA is located
immediately upstream of the 6-His-Tag sequence. This ensured that E. coli pro-
duced CsgA with a C-terminal 6x-His-Tag. First, csgA from E. coli AR3110 (with-
out the sequence coding for the N-terminal secretion signal and the stop codon)
was amplified by PCR. In addition, the backbone of the plasmid pET-24d was am-
plified by an inverse PCR using oligonucleotides that hybridize upstream of the T7
Tag coding sequence and downstream of the multiple cloning site (located between
the T7 Tag and His Tag coding sequence). Both DNA fragments were then joined
by overlap extension PCR. The PCR product was purified and the ends of the
DNA fragment were phosphorylated for the subsequent DNA ligation. For phos-
phorylation, 17 µL of the purified PCR product was mixed with 2 µL 10x T4 DNA
Ligase buffer (Cat- No.B0202S, New England Biolabs) and 1µL T4 Polynucleotide
Kinase (Cat-No. M0201L, New England Biolabs). After 30min of incubation at
37 ◦C, 1µL T4 DNA Ligase (Cat-No. M0202L, New England Biolabs) was added
to the reaction mixture and ligation followed for 1 h at room temperature. The
ligation mixture was transformed into chemically competent E. coli Top10 by heat
shock transformation. Transformants were screened by colony PCR and successful
plasmid construction was verified by DNA sequencing. Finally, chemically compe-
tent E. coli Rosetta DE3 was transformed with pET-24d harbouring csgA.
For protein expression and purification of CsgA, the protocol published by Zhou et
al. [114] was followed with minor exceptions. E. coli Rosetta DE3 cells harbouring
the CsgA expression plasmid were grown overnight at 37 ◦C in 5mL LB medium
supplemented with antibiotics. The next day, the overnight culture was diluted
1:500 into 200mL of fresh medium. Furthermore lactose was added to a final
concentration of 0.05% for induction of protein expression. Bacteria were grown
overnight at 18 ◦C before they were harvested for 20min at 5000 g. The pellet was
resuspended in 20mL of 8M guanidine hydrochloride with continuous stirring for
1 h at room temperature. Centrifugation of the cell lysate for 20min at 4 ◦C and
10,000 g as well as sonication of the supernatant followed. Proteins were purified
from the bacterial lysate using a Protino Ni-TED 2000 Column (Macherey-Nagel).
First, the column was equilibrated with 4mL KPi buffer [114]. Next, the sonicated
supernatant was loaded onto the column. The column was washed in four steps
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- twice with 3mL of KPi buffer and then twice with 3mL of 10mM imidazone
in KPi buffer. Finally, CsgA with a C-terminal 6x-His-Tag was eluted in 7mL of
125mM imidazole in KPi. Eluates were collected in 1mL fractions and stored on
ice immediately. Successful protein purification was verified by Western Blotting.
First, eluted proteins were separated by a discontinuous sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) according to Laemmli [115]. For
this, a 4% stacking gel and 12% resolving gel were used. Afterwards, the proteins
were transferred from the gel onto a nitrocellulose membrane by semi-dry blotting
and detection of proteins was realized by immunofluorescence staining. The mem-
brane was treated with 5% non-fat dry milk in TBS-T to block unspecific binding
before incubation with anti-6x-His-Tag antibodies conjugated to Alexa Fluor 488
and their detection followed.
Purified CsgA was stored at 4 ◦C. After one week of incubation at 4 ◦C, elution
fractions appeared to contain in vitro polymerized fibers (visible by eye).
2.4.3.7 Interaction of phages with artificial biofilms
For biofilm construction in vitro, bacterial cells were represented by fluorescent
microspheres of 0.5 µm or 1 µm in diameter and curli fibers were used as the ex-
clusive biofilm matrix component. First, colloidal particles together with in vitro
polymerized curli fibers were co-incubated under constant shaking for 1 h at room
temperature in order to embed microspheres in the curli fiber network. Simulta-
neously, curli fibers were stained with congo red (final concentration 40 µgmL=1)
in the presence of 1% BSA for fluorescence imaging. Subsequently, a syringe was
loaded with the bead-curli fiber mixture and connected with PTFE tubing to mi-
crofluidic channels. The mixture was introduced into the channels with a flow
rate of 1µLmin=1 for 1.5 h. Numerous pillars regularly arranged in decreasing
distances from each other were present inside the channels. Additionally, the glass
surface of microfluidic channels was coated with poly-L-lysine to facilitate surface
attachment of the artificial biofilms. The surface treatment and presence of pillars
ensured that the biofilms were not washed out of the microfluidic channel. Ar-
tificial biofilms were exposed to T7 phages labelled with Alexa FLuor 488 (final
concentration 108 PFUmL=1) under constant flow (1µLmin=1) for one hour before
fluorescence images were acquired with a confocal microscope.
As a control, clusters made of fluorescent microspheres alone (matrix-free biofilms)
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were exposed to fluorescently labelled T7 phages. Here, microspheres suspended
in PBS with 1% BSA were pelleted at 8000 rpm for 5min. Subsequently, fractions
of the pellet were introduced into microfluidic channels and the clusters were al-
lowed to attach to the poly-L-lysine coated glass surface for 30min. Afterwards,
microfluidic channles were connected to syringes filled with fluorescently labelled
T7 phages (final concentration 108 PFUmL=1). Phages passed through the chan-
nels under a constant flow of 1 µLmin=1 for one hour, before fluorescence imaging
with a confocal microscope took place.
In a second control experiment, in vitro polymerized curli fibers were exposed
to fluorescently labelled T7 phages. For this, curli fibers were stained with congo
red (final concentration 40 µgmL=1) for one hour at room temperature under con-
stant shaking. Afterwards, a syringe was filled with the stained curli fibers and
connected with PTFE tubing to microfluidic channels containing a poly-L-lysine
coated glass surfaces. Numerous pillars arranged in decreasing distances were
present inside the microfluidic channels to ensure that the polymerized curli fibers
were not washed out during constant flow. Curli fibers were introduced into the
microfluidic channels for 1.5 h with a flow rate of 1µLmin=1. Subsequently, these
microfluidic channels were connected to fresh syringes filled with fluorescently la-
belled T7 phages (final concentration 108 PFUmL=1). Phages were introduced
into the channels for one hour under constant flow (1 µLmin=1) before fluores-
cence images were taken using a confocal microscope.
2.4.3.8 Fixation and staining of E. coli AR3110 biofilms
To analyze the architecture of E. coli AR3110 biofilms, it was necessary to fix
and stain the biofilms. For fixation, syringes filled with 4% paraformaldehyde (in
PBS) were connected with PTFE tubing to microfluidic channels containing grown
biofilms. Under constant flow (0.5 µLmin=1) biofilms were fixed for 5 h at room
temperature before staining with 10 µM Syto9 (Cat-No. S34854, Thermo Fischer
Scientific) in PBS followed. During staining for 5 h at room temperature, syringes
filled with the fluorescent dye as well as the microfluidic channels were protected
from light.
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2.4.4 Microscopy and Image Analysis
2.4.4.1 Confocal laser scanning microscopy
Fluorescence images to study the susceptibility of wild type as well as matrix mu-
tant biofilms to phages were acquired with a Yokogawa CSU confocal spinning disk
unit mounted on a Nikon Ti-E inverted microscope using a Nikon 100x oil objec-
tive with 1.45 NA. Fluorescent proteins (sfGFP and mRuby2) were excited with
488 nm and 552 nm lasers, respectively, and emission was detected with an An-
dor iXon electron-multiplying charge-coupled device (EMCCD) camera. During
confocal imaging a 488/552/594 nm dichroic filter as well as 525/50 and 650/150
emission filters were used. For biofilms up to an age of 48 h, images were acquired
every 30min for 12 h with a step size of 0.4 µm in the z-direction. In case of older
biofilms, the time intervall was set to 1 h. During single-cell resolution imaging
for biofilm architecture analyses, an additional 2x lens was placed between the
spinning disk unit and the Nikon Ti-E side port. Furthermore, the step size in the
z-direction was changed to 0.2 µm.
When curli fibers and fluorescently labelled phages were visualized together with
biofilms or transcriptional activity of genes was monitored during biofilm growth,
fluorescent images were acquired with an inverted Zeiss Axio Observer Laser Scan-
ning Microscope (LSM) 880 using a Plan-Apochromat 63x oil objective with 1.4
NA. Images were acquired every 30min or 60min according to the biofilm age, as
described above. The step-size in z-direction was 0.4 µm.
2.4.4.2 Scanning electron microscopy
Scanning electron microsocopy was applied to visualize curli fiber networks around
bacterial cells or as part of the biofilm matrix in artifical biofilms. Additionally,co-
localization of T7 phages with curli fibers was imaged with an scanning electron
microscope.
In order to visualize bacterial cells naturally surrounded by a curli fiber network,
E. coli AR3110 was grown for 5 h at 37 ◦C and 250 rpm shaking. Afterwards, bac-
teria were back-diluted 1:100 in tryptone broth and grown overnight at 28 ◦C and
250 rpm shaking. The next day, 50 µL of the bacterial culture was spotted onto a
poly-L-lysine coated glass slide (thickness 0.17mm). Cells were allowed to attach
to the glass surface for 1 h at room temperature, fixed by placing the glass slide
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into a 4% paraformaldehyde solution for 5min and washed three times in H2O
(5min each). Subsequently, samples were dehydrated in a graded ethanol series.
Here, glass slides were placed in solutions with an increasing ethanol concentra-
tion (30%, 50%, 70%, 90%, 100%) for 5min each. Samples were dried by critical
point drying, sputter coated with platinum for 90 s followed by imaging with a
JEOL JSM-7500F scanning electron microscope. The microscope was operated at
10 kV. Images were analysed using ImageJ.
For scanning electron microscopy of artifical biofilms, biofilms were constructed
as described previously (Chapter 2.4.3.7). Afterwards, they were deposited onto a
poly-L-lysine coated glass slide and processed further.
Visualization of T7 phages bound to curli fibers involved incubation of phages
together with in vitro polymerized fibers for 1 h under constant shaking. After-
wards, unbound phages were removed by centrifugation for 3min at 13,000 rpm.
In addition, curli fibers were washed once with PBS, prior to transferring them
onto a poly-L-lysine coated glass slide and preparing for electron microscopy.
2.4.4.3 Data analysis
Initially, floating cells, that were not associated with a biofilm, were discarded
from the z-stack using median filtering. After denoising by 3D-convolution with
an averaging kernel and Top-hat filtering of out-of-focus fluorescence, bacterial
cells were detected three-dimensionally by a 3D Laplacian-of-Gaussian edge de-
tection algorithm. Subsequently, k-means clustering and/or watershedding was
used to separate clumped structures into individual cells. Temporal differences
in bacterial biomass were quantified using the volume fraction of bacterial cells,
normalized to the biomass at the time, t0, of phage addition.
Spatiotemporal transcription dynamics during biofilm growth were analyzed by
tracking both the projected biofilm height and mKate2 fluorescence intensity along
z-direction for different biofilm ages.
The cell density inside grown biofilms was analyzed by placing a sphere with 3µm
in diameter around each individual biofilm-associated bacterial cell. Afterwards
the fraction of the occupied area inside the sphere by neighbouring cells was calcu-
lated. The analysis code was written in MATLAB (MathWorks) by R. Hartmann
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and is described in more detail in [103].

3 Interaction dynamics of Vibrio
cholerae with macrophages
3.1 Introduction
3.1.1 Vibrio cholerae surface colonization
Vibrio cholerae is a facultative pathogenic Gram-negative bacterium that lives in
aquatic environments [116]. There, V. cholerae forms biofilms on zooplankton and
phytoplankton [117, 118]. Chitin, found in the exoskeleton of zooplankton, can be
utilized by V. cholerae as a carbon source. In addition, growth on chitin has been
shown to induce natural competence [119, 120]. Pathogenic strains of V. cholerae
can invade the human host through oral ingestion of contaminated water, form
biofilms on epithelial cells in the intestine and cause the diarrheal cholera disease
[121]. The virulence factors required for the cholera disease are encoded by the
CTX prophage [122].
Studying V. cholerae biofilm formation on a glass surface in vitro revealed that the
bacterium uses the polar flagellum together with mannose-sensitive hemagglutinin
(MSHA) pili to scan the surface, before attachment occurs [15]. Following attach-
ment, bacteria form a three-dimensional structure. Biofilm formation is controlled
by quorum sensing, a bacterial system for cell-cell-communication that enables
collective behaviour [123, 124]. The V. cholerae biofilm matrix constituents are
vibrio polysaccharide (VPS) and three proteins (RbmA, RbmC, Bap1). Bap1 is
responsible for surface adhesion of the growing biofilm. In contrast, RbmA local-
izes throughout the biofilm and connects cells to each other. A mix of RbmC,
Bap1 and VPS forms an envelope that surrounds cell clusters inside the biofilms.
Production of matrix is essential for biofilm formation on a glass surface. Bacteria
impaired in VPS or matrix protein production are not able to establish a three-
dimensional structure [13, 125]. Dispersal, the last step in biofilm development, is
triggered by a combination of the general stress response (RpoS) and local bacte-
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rial cell densities (via quorum sensing) [11].
Microscopic analysis of intestines after infection with V. cholerae and the investiga-
tion of stool samples of patients confirms V. cholerae biofilm formation inside the
human host [126, 127]. Once V. cholerae penetrates the mucus layer and reaches
the epithelium, the bacterium attaches to the epithelial cells via adhesins present
on the bacterial surface and forms biofilms [126, 128]. Colonization seems to be
dependent on the production of the biofilm matrix components RbmA and VPS
[129]. Furthermore, biofilm formation requires the production of toxin-coregulated
pili (TCP) [130, 131]. The exact mechanism of biofilm formation in the human
intestine and the composition of the biofilm matrix are still unclear.
3.1.2 Mannose-sensitive hemagglutinin and
toxin-coregulated pili
Mannose-sensitive hemagglutinin (MSHA) pili are produced by V. cholerae strains
of the El Tor biotype [132, 133]. The structural subunit of those type IV pili is
the protein MshA [134]. MSHA pili facilitate attachment of V. cholerae not only
to zooplankton but also to glass surfaces [15, 135]. For glass surfaces it has been
show, that MSHA pili together with the polar flagellum promote surface scanning,
before attachment occurs [15]. Colonization of the intestine is however indepen-
dent of MSHA pili [136, 137].
In contrast, toxin-coregulated pili (TCP) facilitate attachment of V. cholerae to
epithelial cells in the intestine and mediate interactions between bacterial cells.
Furthermore, in biofilms formed on epithelial cells, the bacteria are encapsulated
in a matrix made out of toxin-coregulated pili [131, 138]. Toxin-coregulated pili
are encoded by the tcp operon and TcpA is the major subunit of the pilus [139].
Expression of TCP but also cholera toxin is modulated by quorum sensing. At
low cell densities, TcpPH together with ToxRS activate the transcription of toxT.
And ToxT in turn is the transcriptional activator for the expression of virulence
factors including TCP and cholera toxin [140142].
3.1.3 Macrophages - immune cells with phagocytic activity
The innate immune system includes phagocytic cells such as neutrophils and
macrophages in order to eliminate invading bacteria [143]. The human body is
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comprised of tissue-resident macrophages as well as moncyte-derived macropages
[144]. Tissue-resident macrophages can recognize invading microoragnisms by dif-
ferent types of receptors and induce an inflammatory response. As a result, neu-
trophils and monocytes are recruited from the blood to the site of inflammation.
Upon recruitment into tissues, monocytes can differentiate into macrophages [145
149].
After recognition by macrophages, the invading organism is internalized by macro-
phages and a phagosome is formed which matures into a phagolysosome. Phagolyso-
somes are characterized by low pH, the presence of reactive oxygen species as well
as peptidases and hydrolases, all of which contribute to degradation of the invading
mircoorganism [150]. In order to survive in the presence of macrophages, bacteria
have developed different strategies. Those can include survival in the presence of
low pH, interference with phagosome maturation or counteracting macrophage-
derived degrading enzymes [151154]. In addition to single cell protection mecha-
nisms, bacteria can evade phagocytosis by the formation of biofilms [155, 156].
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3.2 Results
Invasion by pathogenic bacteria can be a threat to the human body. Bacteria are
able to colonize human tissues and cause serious diseases. To protect the human
body from invading organisms, the immune system is comprised of phagocytes,
such as neutrophils or macrophages. However, bacteria can develop mechanisms
to evade destruction by phagocytes [143, 151154]. To uncover the mechanism of
how pathogenic bacteria accomplish a stable co-existence with immune cells, the
interaction between macrophages and the biofilm-forming bacterial species Vibrio
cholerae was investigated.
The results described in this chapter have not been published. Bacterial strain
construction and the experimentation was carried out by myself. K. Raveendran
was involved in strain construction. H. Jeckel created custom scripts for image
analysis in MATLAB. K. Drescher initiated the project.
3.2.1 Interaction dynamics of V. cholerae with human
macrophages
In order to study bacterial interactions with immune cells, V. cholerae cells were
incubated with human macrophages (derived from THP-1 monocytes) and the
interaction was monitored by fluorescence confocal mircoscopy. V. cholerae con-
stitutively expressed sfGFP and macrophages were visualized by staining with
CellTracker Red CMPTX (Cat-No. C34552, Thermo Fisher Scientific). As macro-
phages are recognized by their ability to phagocytize bacterial cells, ingestion of
bacteria by the immune cells was expected to be observed during the V. cholerae-
macrophage interaction. However, during co-incubation for 7 h, phagocytosis of
bacteria by the macrophages could not be detected. Instead, V. cholerae en-
circled the macrophages, exhibiting biofilm dynamics on the macrophage surface
(Figure 3.1). The progression of V. cholerae propagation on the surface of macro-
phages was comprised of three stages, as generally seen during the formation of
biofilms. In the first stage, V. cholerae cells attached to the surface of human
macrophages. The second stage included the development of a biofilm on the
macrophage surface. Termination of the interaction by biofilm dispersal repre-
sented the third stage. This time period was accompanied by cell death of the
macrophages. Identification of these stages occurred by visual examination of the
acquired microscopy images. For further characterization, the amount of bacteria
Figure 3.1: Temporal dynamics of the interaction between V. cholerae and hu-
man macrophages. After initial attachment, V. cholerae formed a few cell layers thick
biofilm on the surface of human macrophages (derived from THP-1 monocytes). Ter-
mination of the interaction process by the dispersal of biofilms was accompanied by
macrophage cell death. Representative images in xy-plane show the progression of
the V. cholerae-macrophage interaction. The plotted line represents the mean bacterial
biomass attached to macrophages normalized by the biomass of non-attached bacteria.
The shaded area denotes the standard error of the mean (n=31).
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It was tested if bacterial attachment is limited to the surface of macrophages or
if it can also occur in the presence of macrophage-precursor cells (monocytes).
When V. cholerae was co-incubated with THP-1 monocytes for 1 h, bacterial at-
tachment to the monocytes was attenuated (Figure 3.2 a). Thus, the difference in
attachment between macrophages and their precursor cells indicates selectivity in
the bacterial interaction with immune cells.
Next, it was tested if bacterial biofilm formation depends on the number of macro-
phages or the initial bacterial cell count. Varying the total number of both cell
types revealed that the initial bacterial cell count, but not the the number of
macrophages, plays a crucial role in the establishment of a bacteria-macrophage
interaction. By lowering the bacterial count, accumulation of bacterial biomass
around macrophages and subsequently, biofilm dispersal, was delayed in time or
did not occur at all during co-incubation for 7 h (Figure 3.2 b). Conversely, in-
creasing the bacterial count resulted in faster progression of biofilm formation.
Changing the number of macrophages in the interaction assay did not affect the
V. cholerae-macrophage interaction process.
In conclusion, the interaction between V. cholerae and macrophages involves the
development of bacterial biofilms on a biotic surface. The interaction is charac-
terized by three stages: bacterial attachment, biofilm formation and dispersal of
biofilms. The final stage was also accompanied by macrophage cell death. Bac-
terial attachment to immune cells is specific to macrophages, regardless of their
origin. The pace of the interaction process is determined only by the initial bac-
terial count introduced into the system. In this study, the first two stages of the
interaction were investigated to uncover how V. cholerae attaches to and forms
biofilms on the surface of macrophages.
Figure 3.2: V. cholerae selectively attaches to human macrophages and tempo-
ral dynamics of biofilm formation depend on the initial bacterial cell count. (a)
During co-incubation, V. cholerae attached to macrophages (derived from THP-1 mono-
cytes). In contrast, attachment was significantly decreased in the presence of THP-1
monocytes. Bars represent the mean bacterial biomass attached to immune cells after
one hour of co-incubation, normalized to the macrophage interaction. Errorbars repre-
sent the standard error of the mean (nmacrophage=31; nmonocyte=8 ). Statistical significance
was calculated using an unpaired t-test (**** p<0.0001). (b) By reducing the bacterial
cell count for a given number of macrophages, the formation and dispersal of biofilms
around macrophages was delayed or did not occur at all, regardless of the total number
of macrophages present. Plotted lines represent the mean bacterial biomass attached
to macrophages normalized by the biomass of non-attached cells. Error bars represent
the standard error of the mean (n>3).
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were constructed, thereby removing one of these components from the bacte-
rial surface: toxin-coregulated pilus (TCP, ∆tcpA), mannose-sensitive hemagglu-
tinin (MSHA) pilus (∆mshA), flagellum-regulated hemagglutinin (∆frhC ), GbpA
(∆gbpA), Mam7 (∆mam7 ) or the polar flagellum (∆flaA). After one hour of co-
incubation with macrophages (derived from THP-1 monocytes), V. cholerae cells
lacking flagellum-regulated hemagglutinin, GbpA, Mam7 or TCP were able to
attach to the macrophage surface, similar to the wild type (Figure 3.3). Only
bacteria deficient in flagellum (∆flaA) or MSHA pili (∆mshA) biogenesis were
impaired in macrophage attachment (Figure 3.3). Ectopic expression of flaA or
mshA, under control of the native promoter, in the corresponding deletion mutant
successfully restored the ability for attachment, as seen for wild-type bacteria (Fig-
ure 3.3). Similar results were obtained in interaction studies using macrophages
derived from human blood monocytes (Figure S2). In conclusion, the polar flag-
ellum, together with MSHA pili, is required for attachment of V. cholerae to the
macrophage surface.
Figure 3.3: Flagella and MSHA pili facilitate attachment of V. cholerae to macro-
phages. Macrophages (derived from THP-1 monocytes) were exposed to V. cholerae
lacking components known to facilitate surface attachment. After co-incubation for one
hour, mutants lacking flagellum-regulated hemagglutinin (ΔfrhC), GbpA (ΔgbpA), Mam7
(Δmam7 ) or TCP (ΔtcpA) showed attachment similar to wild-type bacteria. V. cholerae
deficient in assembly of the polar flagellum (ΔflaA) or MSHA pili (ΔmshA) showed im-
paired attachment to the macrophage surface. Ectopic expression of flaA or mshA, un-
der control of the native promoter, successfully restored attachment to macrophages.
Bars represent the mean bacterial biomass attached to the macrophage surface after
one hour of co-incubation, normalized to the wild type. Error bars denote the stan-
dard error of the mean (nWT=31; nΔfrhC=6; nΔgbpA=6; nΔmam7=6; nΔtcpA=12; nΔflaA=5;
nΔflaA, PflaA-flaA=3; nΔmshA=11; nΔmshA, PmshA-mshA=7; nΔmshA ΔflaA=4). Statistical analysis us-
ing a one-way ANOVA, with Bonferroni’s correction for multiple comparisons, confirmed
significant differences in attachment between the wild type and ΔflaA, ΔmshA as well
as ΔmshAΔflaA (**** p<0.0001; *** p<0.01; ns, not significant).
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the ability for macrophage attachment. Flagella appeared to be crucial for sur-
face attachment, as ∆flaA did not show delayed attachment (Figure 3.4 a). To
understand how V. cholerae accomplished attachment in the absence of MSHA
pili, previously tested bacterial surface components were examined once more for
their engagement in delayed attachment. For this, deletion mutants were con-
structed using∆mshA as the background strain. During exposure to macrophages,
∆mshA∆frhC∆gbpA∆mam7 cells showed the same attachment pattern, as seen
for the single deletion mutant ∆mshA (Figure 3.4 a). Thus, flagellum-regulated
hemagglutinin, GbpA as well as Mam7 do not contribute to attachment in the
absence of MSHA pili. In contrast, the removal of TCP in ∆mshA cells was suf-
ficient to prevent attachment of V. cholerae (Figure 3.4 a,b). This suggests that
in the absence of MSHA pili, V. cholerae uses TCP, together with the flagellum,
to facilitate attachment to human macrophages. Similar results could be observed
with macrophages that were derived from human blood monocytes (Figure S4 a).
TCP-mediated delayed attachment suggests that V. cholerae does not produce
TCP from the beginning of co-incubation with macrophages. To test if the pro-
duction of TCP temporally coincides with bacterial attachment to macrophages,
a strain with inducible TCP production was constructed. This was indirectly
achieved by overexpression of ToxT, which is required for the transcription of
tcpA and adequate pilus assembly [157]. Here, toxT was fused to the arabinose
inducible promoter PBAD. When bacteria were grown in the presence of 0.2% ara-
binose, V. cholerae lacking MSHA pili was able to attach to macrophages during
the first hour of co-incubation (Figure 3.4 c). In the absence of arabinose, bac-
teria showed impaired attachment which is in agreement with the result obtained
for ∆mshA cells (Figure 3.3). Overexpression of ToxT in ∆mshA∆tcpA did not
lead to bacterial attachment. Similar results were obtained with macrophages that
were derived from human blood monocytes (Figure S4 b). Thus, overproduction
of TCP shifted the TCP-mediated bacterial attachment to an earlier time point
during exposure to macrophages.
Together, the results reveal dynamics in pili formation on the bacterial surface.
In the absence of MSHA pili, the production of TCP restores the capability of
bacteria to attach to the macrophage.
Figure 3.4: Production of toxin-coregulated pili facilitates bacterial attachment
in the absence of MSHA pili. (a)+(b) V. cholerae impaired in MSHA pili biogenesis
(ΔmshA) adhered to human macrophages (derived from THP-1 monocytes) approxi-
mately 4 h after the start of the co-incubation. Attachment required the polar flagellum,
as ΔflaA cells did not adhere. Furthermore, attachment was independent of flagellum-
regulated hemagglutinin (ΔfrhC) , GbpA (ΔgbpA) and Mam7 (Δmam7 ). In contrast,
removal of TCP (ΔtcpA) together with MSHA pili (ΔmshA) impaired attachment to the
macrophage surface. Representative images in xy-direction show bacterial accumula-
tion around macrophages. Plotted lines represent the mean attached bacterial biomass
normalized by non-attached biomass. Errorbars denote the standard error of the mean
(nWT=31; nΔmshA=11; nΔmshA ΔtcpA=4). (c) Overexpression of toxT under control of the
arabinose inducible promoter pBAD enabled bacteria for TCP-mediated attachment dur-
ing the first hour of co-incubation. Bars represent the mean bacterial biomass attached to
macrophages after one hour of co-incubation, normalized to the interaction with wild-type
bacteria. Error bars denote the standard error of the mean (nΔmshA, 0%=4; nΔmshA, 0.2%=5;
nΔmshA ΔtcpA, 0% =5; nΔmshA ΔtcpA, 0.2% =5). Statistical significance was calculated using an
unpaired t-test (**** p<0.0001; ns, not significant).
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3.2.4 Bacterial biofilm formation on the surface of human
macrophages
The second stage of the interaction process involves the formation of biofilms on
the surface of macrophages. Biofilms are identified by the presence of a self-
produced matrix, that encapsulates the bacterial cells [8]. In order to characterize
the biofilms formed on the macrophage surface, the composition of the matrix was
investigated.
The role of the major matrix components and their local distribution has been
largely described for V. cholerae biofilms grown on a glass surface [13, 125]. The
V. cholerae biofilm matrix constitutes three proteins (RbmA, RbmC and Bap1)
and vibrio polysaccharide (VPS). To determine if these components are important
for biofilm growth on the macrophage surface, a deletion mutant impaired in pro-
duction of all four components (∆rbmA ∆rbmC ∆bap1 ∆vpsL) was constructed.
Upon exposure to macrophages (derived from THP-1 monocytes), V. cholerae was
still able to form biofilms on the surface of macrophages (Figure 3.5). Surprisingly,
the biofilms appeared thicker and were comprised of 2.5 times more biomass as the
ones formed by wild-type bacteria (Figure S3 a). To explain the enhanced biofilm
formation phenotype of ∆rbmA ∆rbmC ∆bap1 ∆vpsL cells, bacterial colonization
of the 96-well glass bottom plate, used for interaction studies, was investigated,
since these components are crucial for colonization of abiotic surfaces. Specifi-
cally, areas not occupied by resident macrophages were analysed for colonization
and biofilm formation by V. cholerae. As compared to wild-type bacteria, approx-
imately three times less bacterial biomass was present in macrophage-free areas
when ∆rbmA ∆rbmC ∆bap1 ∆vpsL bacteria were used in the interaction studies
(Figure S3 b). This suggests that V. cholerae deficient in production of RbmA,
RbmC, Bap1 and VPS is impaired in colonization of the glass surface. Thus, these
bacteria are more likely to encounter macrophages, which results in attachment
and enhanced bacterial biomass accumulation around the immune cells. On the
other hand, wild-type bacteria are able to colonize both surfaces: macrophages, as
well as, the glass surface of the 96-well plate. Accordingly, less bacterial biomass
accumulates on the macrophage surface.
Figure 3.5: Biofilm formation on the macrophage surface depends on the pro-
duction of type IV pili. V. cholerae cells deficient in the production of the major
biofilm matrix components RbmA, RbmC, Bap1 and VPS were able to form biofilms
on the surface of macrophages (THP-1 monocyte derived). Removal of only MSHA
pili or TCP did not impair biofilm growth, for a strain that lacks all major biofilm ma-
trix components. However, V. cholerae lacking MSHA pili and TCP was not able
to form biofilms on macrophages. Loss of biofilm formation was exclusively depen-
dent on the absence of pili and not related to the major matrix components of V.
cholerae biofilms. Representative images in xy-planes show biofilms formed by the
wild type and three biofilm matrix mutants on the surface of macrophages. Bars rep-
resent the mean ratio between bacterial biomass attached to the macrophages sur-
face and biomass present in macrophage-free areas. Error bars denote the standard
error of the mean (nWT=31; nΔrbmA ΔrbmC Δbap1 ΔvpsL=5; nΔrbmA ΔrbmC Δbap1 ΔvpsL ΔmshA=3;
nΔrbmA ΔrbmC Δbap1 ΔvpsL ΔtcpA=3; nΔrbmA ΔrbmC Δbap1 ΔvpsL ΔmshA ΔtcpA=5; nΔmshA ΔtcpA=4).
Statistical significance was calculated using an one-way ANOVA with Bonferroni’s cor-
rection for multiple comparisons (**** p<0.0001; *** p<0.0002).
Figure 3.6: Biofilms formed on the surface of macrophages contain RbmA as part
of the matrix. (a)-(d) Secreted RbmA was visualized by immunofluorescence staining
during co-incubation of human macrophages (derived from THP-1 monocytes) with V.
cholerae expressing RbmA with a C-terminal 6x-His-Tag. After 4 h of co-incubation, se-
creted RbmA was detected in different layers (a-d) of the biofilm. RbmA mostly localized
at the outer boundary of the bacterial community.
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surface (Figure 3.7 a). Complete biofilm dispersal could be observed for ∆rbmA
∆rbmC ∆bap1 ∆vpsL ∆tcpA,as well as, the ∆tcpA single deletion mutant. When
bacteria overproduced TCP, biofilm dispersal from the bacterial surface could not
be observed (Figure 3.7 b). This suggests that TCP is an integral part of the
biofilm matrix of V. cholerae biofilms formed on the surface of macrophages.
Figure 3.7: Toxin-coregulated pili are part of the biofilm matrix and prevent com-
plete biofilm dispersal.(a) Biofilms formed by wild-type bacteria on the surface of
macrophages (THP-1 derived) did not show complete dispersal: approximately 30%
of the bacterial biomass remained attached after 7 h of co-incubation. When bacteria
were deficient in TCP production (ΔtcpA), biofilms dispersed completely. The extent of
biofilm dispersal was independent of the major matrix components of V. cholerae biofilms
(RbmA, RbmC, Bap1, VPS). Representative images in xy-plane show V. cholerae wild-
type and mutant biofilms formed on the macrophage surface. Furthermore, the same
macrophage is shown after 7 h of co-incubation, when biofilm dispersal occurred. Bars
represent the mean fraction of attached bacterial biomass at 7 h after start of the
co-incubation. Error bars denote the standard error of the mean (nWT=31;nΔtcpA=12;
nΔrbmA ΔrbmC Δbap1 ΔvpsL ΔtcpA=3). (b) When bacteria overproduced TCP, dispersal of
biofilms from the macrophage surface was not observed. Images in the xy-plane show
the accumulation of V. cholerae at the time points 1 h and 7h after the initiation of the
co-incubation with macrophages (THP-1 monocyte derived).
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3.3 Discussion and Outlook
The innate immune system includes macrophages with phagocytic activity. Macro-
phages are tissue-resident cells, that confer the first line of defense and recruit neu-
trophils and monocytes from the blood in order to resolve inflammation [143, 144].
Within this study, the interaction between the human biofilm-forming pathogen
V. cholerae and human macrophages was investigated.
Studying the interaction between V. cholerae and macrophages using fluorescence
microscopy revealed the capability of V. cholerae to attach to and initiate biofilm
formation on the surface of human macrophages (Figure 3.1). Phagocytosis of
V. cholerae could not be observed. The ability of V. cholerae to form biofilms
on the surface of immune cells did not extend to macrophage-precursor cells, i.e.
monocytes (Figure 3.2). Propagation on the macrophage surface displayed the
characteristic stages of traditional biofilm formation - attachment, growth and
dispersal. The formation of biofilms on the macrophage surface was facilitated by
the combined action of the polar flagellum and the bacterial type IV pili - MSHA
pili or TCP (Figure 3.3, Figure 3.4). Flagella and MSHA pili were crucial for the
initial attachment of bacteria to macrophages. This interaction was strengthened
by TCP, whose presence prevented complete dispersal of bacteria from the macro-
phage surface (Figure 3.7). Other matrix components, traditionally found in V.
cholerae biofilms formed on an abiotic surface (RbmA, RbmC, Bap1 and VPS),
were dispensable for biofilm growth on the macrophage surface (Figure 3.5).
Attachment of V. cholerae seems to be specific to macrophages and does not occur
during exposure to monocytes. A prerequisite for detection and phagocytosis of
invading bacteria is their recognition by receptors that are present on the macro-
phage surface [158]. This suggests that upon differentiation, V. cholerae is able to
bind those receptors on the macrophage surface. Since attachment of V. cholerae
is facilitated by the presence of a polar flagellum, binding to the marophage surface
could occur via the toll-like receptor 5 (TLR5) that recognizes bacterial flagalla
[159, 160]. In addition to the polar flagellum, V. cholerae requires MSHA pili for
macrophage attachment. MSHA pili are able to bind sugars [161]. This suggests,
that attachment of V. cholerae could be facilitated by binding to glycoproteins
present on the macrophage surface. In addition to MSHA pili, toxin-coregulated
pili facilitated attachment of motile to macrophages. This is in accordance to
previous studies where bacterial colonization by toxin-coregulated pili has been
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established already [157]. In order to fully understand the attachment mechanism,
motility of bacterial cells should be considered. Here, it should be further investi-
gated whether the flagellum is only required for motility or actually interacts with
macrophages and mediates bacterial binding.
V. cholerae biofilm formation on the macrophage surface requires type IV pili as
well. Again, production of MSHA pili or TCP by motile bacteria was sufficient for
surface colonization (Figure 3.5). This suggests, that pili constitute the matrix of
V. cholerae biofilms grown on the surface of macrophages. Toxin-coregulated pili
have been already shown to form a fibrious mesh with encapsulated V. cholerae
cells [157]. Traditional matrix components observed in biofilms formed on a glass
surface (RbmA, RbmC, Bap1 and VPS) are not required for colonization of macro-
phages. This suggests that V. cholerae can adapt to different environments and
form biofilms with different types of matrix components. Since V. cholerae lives
in marine environment and the human intestine, it is not surprising, that this bac-
terium evolved different modes of biofilm formation.
The last step in biofilm formation is dispersal. Dispersal of V. cholerae biofilms
from the macrophage surface is accompanied by cell death of macrophages. Biofilm
dispersal and macrophage death need to be investigated in future experiments.
Preliminary data suggests, that biofilm dispersal is independent of quorum sens-
ing. Time-resolved dual-RNA sequencing could be applied to elucidate the mech-
anisms that trigger biofilm dispersal and macrophage cell death. Furthermore, the
data could help to uncover, why V. cholerae is not phagocytized by macrophages.
Studies with neutrophils showed that those immune cells can not phagocytize V.
cholerae. Impaired phagocytosis was linked to production of toxins by V. cholerae
[162]. This suggests, that V. cholerae could actively evade phagocytosis by immune
cells for efficient colonization of the human intestine.
Material and Methods 75
3.4 Material and Methods
3.4.1 Microbiological Methods
3.4.1.1 Growth of V. cholerae and E. coli
Bacteria were grown overnight in 5mL LB (Lysogeny Broth) medium at 37 ◦C
under shaking conditions (250 rpm). Where necessary, the bacterial culture was
supplemented with antibiotics. Antibiotic concentrations used for liquid cultures
are listed in Table 3.1. Bacterial strains used in this study are listed in Table S3.
Table 3.1: Antibiotic concentrations used for selection of E. coli and V. cholerae
Antibiotic Final concentration [µgmL=1]
Gentamicin 30
Kanamycin 50 (E. coli), 100 (V. cholerae)
Chloramphenicol 10
Streptomycin 5000
3.4.1.2 Storage of V. cholerae and E. coli
Overnight grown bacteria stored as described previously (Chapter 2.4.1.2).
3.4.2 Molecular Cloning
3.4.2.1 Genetic modifications in V. cholerae C6706
Chromosomal modifications in V. cholerae O1 biovar El Tor strain C6706 were
carried out by homologous recombination using the suicide vector pKAS32 [163,
164]. For successful chromosomal integration of the suicide vector into the V.
cholerae genome, two 1000 base pair long DNA fragments flanking the genomic
region of interest were inserted into the pKAS32 vector as described in section
3.4.2.2. Afterwards, the suicide vector was transformed into V. cholerae C6706
by bacterial conjugation. For this, overnight grown E. coli S17-1 λ pir harboring
pKAS32 were washed once and concentrated ten times in LB medium. After-
wards 100µL of overnight grown V. cholerae were mixed with 50 µL concentrated
E. coli cells and spotted onto an LB agar plate. Following incubation for 6 h at
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37 ◦C, bacteria were streaked on an LB agar plate supplemented with Polymyxin
B (50U/mL) and Kanamycin, in order to select for V. cholerae with the pKAS
32 plasmid integrated into the genome. Plates were incubated overnight at 37 ◦C.
The next day, bacteria from two colonies were re-grown for 4 h at 37 ◦C in 1mL
LB medium supplemented with Streptomycin. Afterwards, cells were back-diluted
1:20 and grown for a second time under the same conditions before being finally
diluted 1:107 in LB medium and plated on LB agar supplemented with Strepto-
mycin. Growth in the presence of Streptomycin selects for V. cholerea cells that
underwent a second homologous recombination step and do not harbor the pKAS
32 plasmid in their genome. Clones obtained after overnight growth at 37 ◦C were
screened by colony PCR for the correct genomic modifications. Positive transfor-
mants were re-streaked on LB agar and plates were incubated overnight at 37 ◦C.
Bacteria from one colony were re-grown in liquid culture and stored afterwards.
Chromosomal modifications were verified by DNA sequencing. In order to generate
the DNA fragment for sequencing, the genomic region of interest was amplified by
PCR using PrimeSTAR GXL polymerase (see reaction mixture Table 3.2 and PCR
program Table 3.3) with 0.5 µL of overnight grown bacterial cells as the source of
DNA.
All V. cholerae strains used for bacteria-macrophage interaction studies were trans-
formed with the plasmid pNUT542 (for constitutive production of sfGFP) by bac-
terial conjugation. Overnight grown E. coli Top 10 harboring pNUT542 as well as
E. coli carrying the helper plasmid pRK600 were washed once and concentrated
ten times in LB medium. Afterwards, 50 µL of both concentrated E. coli strains
were mixed with 100µL of overnight grown V. cholerae. The cell suspension was
spotted onto an LB agar plate incubated for 6 h at 37 ◦C. Bacteria were streaked
on an LB agar plate supplemented with Polymyxin (50U/mL) and Gentamicin.
Bacteria were grown overnight at 37 ◦C. The next day, bacteria from one colony
were grown in LB medium supplemented with Gentamicin overnight at 37 ◦C and
stored afterwards.
3.4.2.2 Plasmid construction by Gibson assembly
Gibson assembly was applied to construct suicide plasmids based on pKAS32 for
genetic modifications in V. cholerae. Individual DNA fragments, with 20-30 bp
long overlap regions for fusion by Gibson assembly, were first generated in a PCR
Material and Methods 77
and purified. Subsequently, the Gibson assembly reaction mixture was prepared
on ice as described in [165] for one-step isothermal DNA assembly. Here, 200 ng
of the pKAS vector and equimolar amounts of the inserts (DNA fragments to be
joined with pKAS32 vector) were added to 7.5 µL of the assembly master mixture
in a total volume of 10µL. The reaction mixture was placed for 20min at 50 ◦C
and 350 rpm shaking. Afterwards, the reaction mixture was cooled on ice for 5min
and the assembled plasmid was transformed into E. coli S17-1 λ pir by heat shock.
Bacteria harboring the assembled plasmid (as verified by colony PCR) were grown
in liquid culture and stored afterwards. In addition, the plasmid was isolated (see
chapter 2.4.2.3) and sent for DNA sequencing (see chapter 2.4.2.9).
3.4.2.3 Polymerase chain reaction (PCR)
For Gibson assembly or generation of DNA fragments for subsequent DNA se-
quencing, DNA fragments were amplified using PrimeSTAR GXL polymerase
(Cat-No. R050A, Takara). The composition of the reaction mixture and the PCR
program are listed in Table 3.2 and Table 3.3. Amplification of DNA fragments was
verified by agarose gel electrophoresis (see chapter 2.4.2.6). When plasmid DNA
was used as the template in the PCR, the resulting PCR product was treated with
the restriction endonuclease DpnI (see chapter 2.4.2.7).
Table 3.2: PCR reaction mixture using PrimeSTAR GXL DNA polymerase
Reagent
Reaction Buffer 1x
Oligonucleotide 1 10µM
Oligonucleotide 2 10µM
dNTP 0.2mM
PrimeSTAR GXL
DNA polymerase
0.63U
DNA template 50 ng genomic or plasmid DNA
Total volume 50µL
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Table 3.3: PCR program using PrimeSTAR GXL DNA polymerase
Step Temperature [◦C] Time [min] Cycle
Initial Denaturation 98 5 1
Denaturation 98 0.5
30Annealing 57-60 0.5Elongation 68 0.5/kbp
Final Elongation 68 10 1
Genetic modifications in V. cholerae were verified by colony PCR. For this, trans-
formants were re-grown in 100µL LB medium (supplemented with 5mgmL=1
Streptomycin) in plastic 96-well plates for 30min at 37 ◦C and 250 rpm shaking.
Subsequently, 1 µL of the grown bacterial culture was used as the source of DNA
within the PCR reaction. The composition of the PCR reaction mixture and the
PCR program are listed in Table 2.6 and Table 2.7.
3.4.2.4 Heat shock transformtion of E. coli S17-1 λ pir
Chemically competent E. coli S17-1 λ pir were mixed with 10 µL of the Gibson
assembly reaction mixture and incubated for 30min on ice. Afterwards, heat
shock was applied by transferring bacteria to a 42 ◦C waterbath for 1min followed
by incubation on ice for 2min. Cells were recovered in LB medium (500 µL) and
grown for 2 h at 37 ◦C and 550 rpm shaking. Finally, cells were plated on LB agar
supplemented with the appropriate antibiotic and grown overnight at 37 ◦C. The
next day, transformants were verified by colony PCR (see Table 2.6 and Table 2.7).
3.4.3 Mammalian Cell Culture Techniques
3.4.3.1 Cultivation of the human monocytic cell line THP-1
THP-1 cells were grown at 37 ◦C and 5% CO2 in Dulbecco's Modified Eagle
Medium (DMEM, Cat-No. 11880-028, Thermo Fisher Scientific) supplemented
with GlutaMAXTM (Cat-No. 35050-038, Thermo Fisher Scientific), 10% heat-
inactivated fetal calf serum (FCS, Cat-No. 10500064, Thermo Fisher Scientific)
and Gentamicin (30µgmL=1). Monocytes were subcultured every 2-4 days and
maintained at density of approximately 2.5× 105 cellsmL=1. Before every subcul-
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ture, the cell density was determined using a hemocytometer. Cells were subcul-
tured until passage number 12 was reached, before fresh cells were thawed.
3.4.3.2 Cryopreservation of mammalian cells
At a low passage number and when cells reached a density of approximately
2.5× 105 cellsmL=1, cells were harvested by centrifugation for 5min at 200 g. Af-
terwards, the cell pellet was resuspended in FCS+10% DMSO at a cell density
of 1.5× 106 cellsmL=1 and cryogenic tubes were filled with 1mL of the cell sus-
pension. Subsequently, the vials were placed in a freezing container (Mr. Frosty,
Cat-No. 5100-0001, Thermo Fisher Scientific) and cooled down at a low freez-
ing rate overnight at =80 ◦C. Finally, frozen cells were transferred into a liquid
nitrogen filled storage tank.
3.4.3.3 Thawing mammalian cells
Frozen cells were thawed for 3min at room temperature. Afterwards 5mL of pre-
warmed growth medium was added and the cells were pelleted at 200 g for 5min.
Subsequently, THP-1 cells were resuspended in 10mL growth medium, transferred
into a culture flask and grown at 37 ◦C and 5% CO2.
3.4.3.4 Isolation of monocytes from buffy coat
Isolation of monocytes from buffy coat was performed by Marina Aznaourova (In-
stitute for Lung Research, Philipps-University Marburg). Monocytes were isolated
using CD14 MicroBeads (Cat-No. 130-050-201, Miltenyi Biotec).
3.4.3.5 Differentiation of human monocytic THP-1 cells into
macrophages
THP-1 cells were differentiated in 96-well glass bottom plates (Cat-No. 655892,
Greiner Bio-One) in the presence of Phorbol 12-myristate 13-acetate (PMA, Cat-
No. P1585-1MG, Sigma Aldrich). First, monocytes were harvested for 5min at
200 g and resuspended in fresh growth medium to a cell concentration of 105monocytes/mL.
Next, PMA was added (final concentration: 20 nM) and 200µL of the cell sus-
pension (25,000 cells) was transferred into individual wells of the 96-well plate.
Monocytes were differentiated for 72 h at 37 ◦C and 5% CO2.
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3.4.3.6 Differentiation of monocytes derived from human blood into
macrophages
After isolation of monocytes from buffy coat, the cells were differentiated into
macrophages using X-VIVO-15 serum-free hematopoietic cell medium supplemented
with 5% FBS Superior (Biochrom GmbH), Gentamicin (25 ngmL=1) and 15 ngmL=1
recombinant human GM-CSF (Cat-No. 300-03, PeproTech). For differentiation,
primary monocytes were resuspended in differentiation medium to a cell concen-
tration of 4× 105 cells/mL. Afterwards 200 µL of the cell suspension (80,000 cells)
were transferred into individual wells of a 96-well glass bottom well plate where
cell differentiation occurred for eight days at 37 ◦C and 5% CO2. After four days,
50 µL of fresh differentiation medium was added to each well.
3.4.4 Bacteria-Macrophage Interaction Assay
3.4.4.1 Staining of mammalian cells
After differentiation of THP-1 cells or primary monocytes, the medium was re-
moved and 100 µL of 3mM CellTracker Red CMTPX (Cat-No. C34552, Thermo
Fisher Scientific) staining solution (in Hanks Balanced Salt Solution, HBSS) was
added to the macrophages. Following incubation for 15min at 37 ◦C and 5% CO2,
the staining solution was removed and the cells were washed once with 100 µL
HBSS. Subsequently, bacteria were added to the wells.
For staining of monocytes, cells were harvested for 5min at 200 g and resuspended
in 500 µL staining solution. After incubation for 15min at 37 ◦C and 5% CO2, the
staining solution was removed by centrifugation for 5min at 200 g and monocytes
were resuspended in fresh growth medium to a cell concentration of 105 cells/mL.
3.4.4.2 Exposure of mammalian cells to bacteria
For bacteria-macrophage interaction studies, bacterial cells were grown in 500µL
LB medium at 37 ◦C for 2 h. Afterwards, 20µL of the bacterial culture was trans-
ferred into 5mL DMEM (supplemented with GlutaMax, FCS and Gentamicin)
and the cells were re-grown for 12 h at 37 ◦C. Bacteria from 100µL of the grown
culture were harvested for 1min at 11,000 rpm, resuspended in equal volume us-
ing fresh DMEM (supplemented) and diluted to an OD600 nm of 0.01. Finally,
200 µL of the diluted bacterial suspension was added to stained macrophages re-
siding in 96-well plates and co-incubation for 6 h at 37 ◦C and 5% CO2 followed.
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During co-incubation, fluorescence images were taken using a confocal microscope.
As a control, monocytes were exposed to V. cholerae. For this, bacteria were
grown and prepared for the interaction study as described above with one excep-
tion. Bacteria were diluted to an OD600 nm of 0.1 (instead of 0.01). Afterwards,
200 µL of stained monocytes (corresponding to 25,000 cells) and 1 µL of the bac-
terial suspension was added to individual wells of a 96-well glass bottom plate.
Subsequently, fluorescence images were taken with a confocal microscope.
3.4.4.3 Visualization of dead macrophages
In order to visualize dead macrophages during bacteria-macrophage interaction
studies, the growth medium was supplemented with NucRed Dead 647 (Cat-No.
R37113, Thermo Fisher Scientific). For this, the dye was diluted 1:70 in growth
medium.
3.4.4.4 Visualization of RbmA inside biofilms
The presence of secreted RbmA within biofilms was confirmed by immunofluores-
cence staining. Macrophages were exposed to V. cholerae expressing RbmA with
a C-terminal 6x-His-Tag during bacteria-macrophage interaction studies. After
4 h of co-incubation, anti-6x-His-Tag antibodies conjugated to Alexa Fluor 647
(0.2 µgmL=1, Cat-No. 35370, Qiagen) and bovine serum albumin (1mgmL=1)
were added to the well. Subsequently, fluorescence images were taken with a con-
focal microscope.
3.4.5 Microscopy and Image Analysis
3.4.5.1 Confocal laser scanning microscopy
To study the interaction between V. cholerae and macrophages, fluorescence im-
ages were acquired with a Yokogawa CSU confocal spinning disk unit mounted on
a Nikon Ti-E inverted microscope using a Nikon 40x Plan Fluor oil objective with
1.3 NA. Fluorescent proteins sfGFP and mRuby3 were excited with 488 nm and
552 nm lasers, respectively. Dyes, CellTracker Red CMTPX and NucRed Dead
647, were excited with 552 nm and 640 nm lasers. Emission was detected with an
Andor iXon electron-multiplying charge-coupled device (EMCCD) camera. Dur-
ing confocal imaging a 405/488/552/640 nm dichroic filter, as well as a 525/50,
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650/150 and 731/137 emission filter, were used. The hardware was controlled us-
ing μManager [166]. Images were acquired every 30min with a step size of 3µm
in z-direction.
3.4.5.2 Data analysis
Z-stacks of bacterial biofilms, obtained by fluorescent confocal microscopy, were
analyzed slice-by-slice by dynamic thresholding. Out of the five slices of the z-
stack, only the 3 upper most xy-planes were analyzed. Threshold values for the
identification of bacterial cells from intensity images were determined by Otsu's
method [167], assuming three classes, of which two are assumed to correspond to
the background. Identified cells smaller than 10 pixels were discarded, under the
assumption that those are most likely artefacts of salt-and-pepper noise.
Macrophages were identified by applying the same Otsu-thresholding as described
above. A subsequent series of morphological operations was applied to smoothen
the shape of identified macrophages with objects smaller than 500 pixels discarded,
as they are most likely noise. As observations showed that bacteria attach to,
but do not enter, macrophages, bacterial cells that were not within a distance of
15 pixel to the identified macrophage surface were discarded resulting in a binary
image of the sole attached bacterial cells. Macrophages at the image boundary
were discarded.
Based upon those images, attachment was determined as the areal fraction of
macrophage-attached cells and macrophages. Biofilm formation was quantified
using the areal fraction of bacterial cells within a distance of 20 pixel around the
macrophages and bacterial cells in the space between macrophages. The analysis
code was written in MATLAB (MathWorks) by H. Jeckel.
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Figure S1: Interaction dynamics between V. cholerae and macrophages derived
from human blood monocytes. V. cholerae attached to the surface of human macro-
phages. Attachment was accompanied by bacterial biofilm formation and subsequent
dispersal of the biofilms. The interaction process was further characterized by death of
the macrophages.
Figure S2: V. cholerae uses the polar flagellum and MSHA pili for attachment to
the surface of macrophages derived from human blood monocytes. Deletion mu-
tants, impaired in the production of cell surface components known to facilitate surface
attachment, were tested for colonization of the macrophage surface. Bacteria lacking
flagellum-regulated hemagglutinin (ΔfrhC), GbpA (ΔgbpA), Mam7 (Δmam7 ) and TCP
(ΔtcpA) were able to attach to the macrophage surface, similar to the wild type. By
the removal of the polar flagellum (ΔflaA) or MSHA pili (ΔmshA), the ability for macro-
phage attachment by V. cholerae was significantly attenuated. Ectopic expression of
flaA or mshA, under control of the native promoter, could restore macrophage attach-
ment. Bacteria were able to adhere efficiently, as observed for wild-type cells. Bars
represent the mean bacterial biomass attached to the macrophage surface after one
hour of co-incubation, normalized to the wild type. Errorbars denote the standard error
of the mean (nWT=8; nΔfrhC=3; nΔgbpA=3; nΔmam7=3; nΔtcpA=5; nΔflaA=5; nΔflaA, PflaA-flaA=4;
nΔmshA=6; nΔmshA, PmshA-mshA=4; nΔmshA ΔflaA=3). P values were calculated using one-way
ANOVA (**** p<0.0001; *** p<0.02; ns, not significant).
Figure S3: Biofilm formation on the macrophage surface does not depend on the
matrix components RbmA, RbmC, Bap1 and VPS. (a) V. cholerae impaired in RbmA,
RbmC, Bap1 and VPS production was able to form biofilms on the surface of macro-
phages (derived from THP-1 monocytes). Bars represent the mean ratio between bacte-
rial biomass attached to macrophages and biomass present in macrophage-free areas.
Errorbars denote the standard error of the mean (nWT=31; nΔrbmA ΔrbmC Δbap1 ΔvpsL=5).
The p value was calculated using a two-tailed unpaired t-test (**** p<0.0001). (a)+(b)
Differences with respect to biomass accumulation could be observed between wild-type
bacteria and the matrix mutant. As compared to the wild type, the matrix mutant pri-
marily localized on the surface of macrophages, than in macrophage-free areas. Bars
represent the mean bacterial biomass present in the macrophage-free area. Errorbars
denote the standard error of the mean (nWT=31; nΔrbmA ΔrbmC Δbap1 ΔvpsL=5). The p value
was calculated using a two-tailed unpaired t-test (**** p<0.002).
Figure S4: Production of TCP enables bacterial attachment, in the absence of
MSHA pili. (a) V. cholerae deficient in MSHA pili biogenesis (ΔmshA) showed atten-
uated attachment during the first hour of co-incubation with macrophages that evolved
from human blood monocytes. However, approximately after 3 h, cells initiated attach-
ment and formed biofilms on the macrophage surface. Attachment was achieved by
TCP, as biofilm formation could not be observed for ΔmshA ΔtcpA cells. (b) With the
overproduction of TCP, bacterial attachment was shifted to an ealier time point during co-
incubation. For overproduction of TCP by V. cholerae, toxT was fused to the arabinose
inducible promoter PBAD and bacteria were grown in the presence of 0.2% arabinose.
Overproduction could compensate for the loss of MSHA pili and resulted in bacterial at-
tachment to macrophages that derived from human blood monocytes. Attachment was
dependent on TCP production, as ΔmshA ΔtcpA cells were attenuated in coloniza-
tion of the macrophage surface. Bars represent the mean bacterial biomass attached
to the macrophage surface after one hour of co-incubation, normalized to the interac-
tion with wild-type bacteria. Errorbars denote the standard error of the mean (nWT=8;
nΔmshA, 0%=5; nΔmshA, 0.2%=4; nΔmshA ΔtcpA, 0% =3; nΔmshA ΔtcpA, 0.2% =5). The p value was
calculated using a two-tailed unpaired t-test (** p<0.002; ns, not significant).
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Table S1: Bacterial strains and bacteriophages used for phage-biofilm interaction stud-
ies.
Strain Relevant markers & genotype Source
KDE474 E. coli AR3110 WT Serra et al.
KDE679 AR3110, with Ptac_mRuby2 and Kan
R inserted at attB site (Ptac
without operator).
This study
KDE702 AR3110, with ΔcsgB ::scar, Ptac_mRuby2 and KanR inserted at
attB site (Ptac without operator).
This study
KDE722 AR3110, with ΔfliC ::scar, Ptac_mRuby2 and KanR inserted at
attB site (Ptac without operator).
This study
KDE726 AR3110, with ΔbcsA::scar, Ptac_mRuby2 and KanR inserted at
attB site (Ptac without operator).
This study
KDE956 AR3110, with ΔpgaC ::scar, Ptac_mRuby2 and KanR inserted at
attB site (Ptac without operator).
This study
KDE965 AR3110, with ΔwcaE ::CmR, Ptac_mRuby2 and KanR inserted at
attB site (Ptac without operator).
This study
KDE729 AR3110, with ΔflhDC ::scar, Ptac_mRuby2 and KanR inserted at
attB site (Ptac without operator).
This study
KDE755 AR3110, with ΔcsgA::scar, Ptac_mRuby2 and KanR inserted at
attB site (Ptac without operator).
This study
KDE757 AR3110, with ΔcsgBA::scar, Ptac_mRuby2 and KanR inserted at
attB site (Ptac without operator).
This study
KDE1309 AR3110, with ΔfimA::scar, Ptac_mRuby2 and KanR inserted at
attB site (Ptac without operator).
This study
KDE813 AR3110, with point mutation inside csgD promoter according to
ref (24), Ptac_mRuby2 and Kan
R inserted at attB site (Ptac with-
out operator).
This study*
KDE780 AR3110, with ΔcsgB ::scar, complementation, csgB with native
promoter inserted at attB site Ptac_mRuby2 and Kan
R inserted
at attB site (Ptac without operator).
This study
KDE771 AR3110, with csgBAC -mKate2 transcriptional fusion,
Ptac_mKOk and Kan
R inserted at attB site (Ptac without
operator).
This study
KDE782 AR3110, with fliC -mKate2 transcriptional fusion, Ptac_mKOk
and KanR, inserted at attB site (Ptac without operator).
This study
KDE1005 AR3110, with dgcC -mKate2 transcriptional fusion, Ptac_mKOk
and KanR inserted at attB site (Ptac without operator).
This study
*: Promoter mutation from Grantcharova et al.
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Table S2: Bacterial strains and bacteriophages used for phage-biofilm interaction studies
(continued).
Strain Relevant markers & genotype Source
KDE1062 AR3110, with pgaC -mKate2 transcriptional fusion,
Ptac_mKOk and Kan
R inserted at attB site (Ptac without
operator).
This study
KDE1020 AR3110, with wcaE -mKate2 transcriptional fusion,
Ptac_mKOk and Kan
R inserted at attB site (Ptac without
operator).
This study
KDE1330 AR3110, with fimA-mKate2 transcriptional fusion,
Ptac_mKOk and Kan
R inserted at attB site (Ptac without
operator).
This study
KDE923 AR3110, with CsgA with C-terminal 6x His Tag (from
chromosome, native site), csgBAC -mKate2 transcrip-
tional fusion, Ptac_mKOk and Kan
R inserted at attB site.
This study
KDE931 E. coli Rosetta DE3 transformed with plasmid pNUT915,
which is a pET plasmid with csgA-C-terminal 6x His Tag
in front of the T7 promoter.
This study
KDE1128 AR3110, ΔfliC ::scar, csgA with C-terminal 6x His Tag
(from chromosome, native site), csgBAC -mKate2 tran-
scriptional fusion, Ptac_mKOk and Kan
R inserted at attB
site
This study
KDE1130 AR3110, ΔflhDC ::scar, csgA with C-terminal 6x His Tag
(from chromosome, native site), csgBAC -mKate2 tran-
scriptional fusion, Ptac_mKOk and Kan
R inserted at attB
site
This study
KDE1215 AR3110, ΔfliC ::scar, csgA with C-terminal 6x His Tag
(from chromosome, native site), fliC-sfgfp transcrip-
tional fusion, csgBAC-mKate2 transcriptional fusion,
Ptac_mKOk and Kan
R inserted at attB site
This study
KDH35 WT phage T7 DSMZ (DSM-4623)
KDH37 T7 with sfgfp under control of the phi 10 promoter. This study
KDH52 WT phage T5 DSMZ (DSM-16353)
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Table S3: Bacterial strains used for V. cholerae-macrophage interaction studies.
Strain Relevant markers & genotype Source
S17 E. coli ΔlacU 169 (ΦlacZΔM15), recA1, endA1, hsdR17, thi -1,
gyrA96, relA1, λ pir
TOP10 E. coli mcrAΔ(mrr-hsdRMS-mcrBC) Φ
80lacZΔM15ΔlacX74deoRrecA1 araD139Δ(ara-leu)7697 galU
galK rpsL endA1 nupG
KV201 V. cholerae C6706 (O1 El Tor, SmR)/ Wild type
KDV296 V. cholerae C6706 contains plasmid pNUT542 [11]
KDV1301 V. cholerae C6706 ΔfrhC contains plasmid pNUT542 This study
KDV1323 V. cholerae C6706 ΔgbpA contains plasmid pNUT542 This study
KDV1307 V. cholerae C6706 Δmam7 contains plasmid pNUT542 This study
KDV1305 V. cholerae C6706 ΔtcpA contains plasmid pNUT542 This study
KDV956 V. cholerae C6706 ΔflaA contains plasmid pNUT542 This study
KDV1987 V. cholerae C6706 ΔflaA, PflaA-flaA contains plasmid pNUT542 This study
KDV1303 V. cholerae C6706 ΔmshA contains plasmid pNUT542 This study
KDV1916 V. cholerae C6706 ΔmshA, PmshA-mshA contains plasmid
pNUT542
This study
KDV1775 V. cholerae C6706 ΔmshA ΔflaA contains plasmid pNUT542 This study
KDV1360 V. cholerae C6706ΔmshAΔfrhC ΔgbpAΔmam7 contains plasmid
pNUT542
This study
KDV1776 V. cholerae C6706 ΔmshA ΔtcpA contains plasmid pNUT542 This study
KDV1733 V. cholerae C6706 ΔrbmA ΔrbmC Δbap1 ΔvspL contains plasmid
pNUT542
This study
KDV1752 V. cholerae C6706 ΔrbmA ΔrbmC Δbap1 ΔvspL ΔmshA contains
plasmid pNUT542
This study
KDV1753 V. cholerae C6706 ΔrbmA ΔrbmC Δbap1 ΔvspL ΔtcpA contains
plasmid pNUT542
This study
KDV1770 V. cholerae C6706 ΔrbmA ΔrbmC Δbap1 ΔvspL ΔmshA ΔtcpA
contains plasmid pNUT542
This study
KDV1730 V. cholerae C6706 expressing RmbA with a C-terminal 6x-His-Tag
contains plasmid pNUT542
This study
KDV1959 V. cholerae C6706 ΔmshA, PBAD-toxT contains plasmid pNUT542 This study
KDV1960 V. cholerae C6706 ΔmshA ΔtcpA, PBAD-toxT contains plasmid
pNUT542
This study
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Table S4: Chemicals used.
Chemical Cat-No. and Supplier
EZ-Vision Three N313-Kit VWR
LB-Medium X968.3 Carl Roth
LB-Agar X969.3 Carl Roth
Polyethylene glycol 6000 0158.4 Carl Roth
Bacto Tryptone 211705 Becton Dickinson
Glycerol 3783.2 Carl Roth
Agarose NEEO ultra-quality 2267.3 Carl Roth
Calcium chloride C5670-100G
Caesium chloride 7878.1 Carl Roth
Sodium chloride HN00.2 Carl Roth
Poly-L-Lysine Solution P8920-100ML Sigma Aldrich
Streptomycin sulphate HP66.3 Carl Roth
l(+)-Rhamnose monohydrate 4655.1 Carl Roth
Dimethyl sulphoxide 4720.4 Carl Roth
Guanidin hydrochloride 0035.1 Carl Roth
Bovine Serum Albumin A3059-10G Sigma Aldrich
Chloramphenicol 3886.1 Carl Roth
Ampicillin sodium salt K029.2 Carl Roth
Kanamycin sulphate T832.3 Carl Roth
Gentamycin sulphate 0233.3 Carl Roth
Sylgard 184 silicone elastomer Dow Corning
FluoSpheresTM Size Kit #1 F8887 Thermo Fischer Scientific
